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ADIPOSE SENSORY NERVES: FUNCTIONAL AND NEUROANATOMICAL EVIDENCE
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by
John Thomas Garretson Jr.
Under the Direction of Geert J. de Vries, PhD

ABSTRACT
White adipose tissue (WAT) lipolysis is initiated via direct sympathetic nervous
system (SNS) innervation and activation. SNS control to WAT is vital to maintaining
homeostasis in response to metabolic challenges such as food deprivation and cold
exposure. Using transneuronal viral tract tracers, we have identified sensory nerves
from WAT that project to brainstem and forebrain areas critical to metabolic function.
In addition, these sensory circuits from fat communicate with SNS outflow neurons that
project back to fat—forming neural feedback loops throughout the CNS—providing
neuroanatomical evidence for sensory WAT-SNS crosstalk. It is unclear, however, what
role these WAT-specific sensory nerves serve to inform the CNS of acute and dynamic
metabolic challenges to which it can then respond. Here we tested mechanisms of
activation of WAT sensory nerves and present a working model to deepen our
understanding of why these neural circuits act as conduits for acute metabolic feedback
signals from WAT. Neurochemical, neuroanatomical, and neurophysiological evidence
supports the presence of: 1) WAT lipolytic sensors from a neural population known to be
capable of controlling SNS outflow; and 2) functional neural links among fat depots
mediated via the peripheral and central nervous systems.
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1

INTRODUCTION

The U.S. census reports that 67% of Americans are overweight or obese, creating
a healthcare-related economic burden that exceeds $140 billion annually ("Centers for
Disease Control and Prevention ", 2009). Complications of obesity include
hypertension, cardiovascular disease, type II diabetes, stroke and some cancers
("Centers for Disease Control and Prevention ", 2009) and contribute to up to 26.8% of
U.S. deaths annually (Masters et al., 2013). Clearly, uncovering effective obesity reversal
strategies will improve the health of millions of people, reduce obesity-related deaths,
and decrease healthcare costs associated with increased body fat. A relatively unstudied
facet of obesity reversal is the investigation of neural circuits that emanate from fat
tissue and are networked to brain regions capable of controlling energy balance via the
sympathetic nervous system (SNS). With the exception of the largely unsuccessful
efforts to reverse so-called ‘leptin resistance’ to the adipose-derived satiety hormone
(Myers et al., 2012), few studies have examined the functional connectedness of fat
tissue to the brain as a means to counteract obesity. Therefore, the purpose of this
dissertation is to review our current knowledge of adipose afferent nerve sensitivities
and functions, demonstrate new and physiologically relevant functions of these nerves,
and consolidate this new information into a synthetic working model in order to
generate testable hypothesis regarding the emerging role of adipose afferent nerves in
energy balance.
1.1

Global obesity and its reversal
People who are overweight (BMI = 25 through 30) or obese (BMI > 30) are at

risk for deleterious comorbidities, many of which are associated with the ectopic and
overabundant storage of white adipose tissue (WAT). As of 2014, this includes
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approximately 1.9 billion individuals around the globe: 39% of all adults worldwide; and
this number has more than doubled since 1980 (W.H.O., 2014). Thankfully, body mass
reduction by diet and exercise can attenuate or even resolve symptoms of obesityinduced hypertension, type 2 diabetes (Lewis, 2013), respiratory distress (Dattani,
Swerner, Stradling, & Manuel, 2016), infertility (Dag & Dilbaz, 2015), and sleep apnea
(Quintas-Neves, Preto, & Drummond, 2016). This shift in healthiness by fat reduction
may be due to many factors associated with better diet and exercise (Dankel, Loenneke,
& Loprinzi, 2016); however, surgical removal of white fat also rapidly alleviates
comorbidity symptoms such as insulin insensitivity and hyperlipidemia (Crahay & Nizet,
2016). This suggests that the presence of fat itself produces negative consequences.
Clearly, WAT mass reduction by better diet and exercise is healthful and therefore a
variety of obesity reversal strategies have been employed. In order to discover the many
possible ways permanent obesity reversal may be accomplished, we must know how fat
depot size is regulated and functionally how to control this regulation.
1.2 Introduction to adipose tissue
Adipocytes, or fat cells, vary in size and structure and perform a variety of
specialized functions throughout the body. Two primary types of adipocytes each
comprise large depots throughout the body known as WAT and brown adipose tissue
(BAT) (Fig. 1), whose similarities and differences will be discussed in detail here.
However, other types of fat are not trivial and exist in bone, joints, ectopically within
other organs, and are reviewed elsewhere (Grundy, 2016; Mace, Bhatti, & Anand, 2016;
Scheller, Cawthorn, Burr, Horowitz, & MacDougald, 2016). In general, WAT adipocytes
store excess energy in the form of triglycerides (TAG) and BAT adipocytes expends
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energy by burning lipid during nonshivering thermogenesis. This broad dichotomy often
brings one to assume WAT is bad and BAT is good; however, this conclusion is
somewhat flawed. White fat mobilization is engaged when glucose stores have been
depleted, thus fuel utilization after the exhaustion of or beyond the rate provided by
WAT reflect a state of extreme depletion. This results in wasting and associated
consequences (Kyle & Pichard, 2006)—with obesity being a possible evolutionary
survival strategy to prevent wasting (Prentice, 2005). Lipodystrophy—a disorder
characterized by the inability to store fat at appropriate sites—is associated with a
spectrum of disorders including insatiable appetite, insulin resistance, and cardio
myopathies (Seip & Trygstad, 1996). WAT, conversely, becomes extremely unhealthy
after unregulated accumulation that inevitably leads to its sometimes fatal
comorbidities (Lewis, 2013). BAT, on the other hand, is primarily considered beneficial
and performs thermogenic and glucoregulatory functions (van Marken, 2012). Its
energy consumption often correlates with fat loss and the general reversal of obesity
(Cannon & Nedergaard, 2004b; Carey & Kingwell, 2013; Nedergaard, Bengtsson, &
Cannon, 2011). Although WAT and BAT are both types of adipose tissues, their
metabolic functions, regulatory mechanisms, and even cell lineages are remarkably
distinct (Carey & Kingwell, 2013; Wu et al., 2012).
1.2.1 Brown adipose tissue (BAT) physiology
Largely studied in rodents but also shown to be active in humans (Nedergaard,
Bengtsson, & Cannon, 2007), BAT is a thermogenic tissue that expends energy and is
thus an important contributor to the energy balance equation (Carey & Kingwell, 2013).
Human BAT is more active in winter months (Au-Yong, Thorn, Ganatra, Perkins, &
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Figure 1. Adipose distribution (Tchkonia et al., 2013) and cellular ultrastructure of WAT
and BAT (Cinti, 1999).
a-b) Figure from (Tchkonia et al., 2013). a) Rodent and b) human distribution of WAT and BAT. c-d)
Figure from (Cinti, 1999). Electron microscopy of c) epididymal white and d) interscapular brown
adipocytes: n, nucleus; m, mitochondria; L, lipid droplet; CAP, capillary.

Symonds, 2009) and is acutely activated by cold (Sacks et al., 2013). Its activity also
contributes to better glucose regulation and reduced risk for type 2 diabetes (Cannon &
Nedergaard, 2004a). In rodents, BAT is localized primarily in the interscapular region
(Tchkonia et al., 2013) but also in pericardial, subclavical, and supraspinal regions;
whereas, human primary BAT depots are pericardial, subclavical, supraspinal and are
absent from the interscapular region in adulthood (Tchkonia et al., 2013) (Fig. 1a, b).
Indeed, animals with higher BAT activity tend to be thinner, more glucose tolerant, and
illustrate a healthier inflammatory profile than their counterparts with low BAT activity
(Krief, Bazin, Dupuy, & Lavau, 1989; Stanford et al., 2013; Vijgen et al., 2012). In
addition, many clinical investments target BAT activation as a strategy to treat human
obesity. Therefore, recent research initiatives have focused on BAT growth, BAT activity,
BAT transplantation in BAT deficient animals, and the browning of WAT to resemble
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BAT all to test how this tissue contributes to better metabolic health (Carey & Kingwell,
2013).
BAT adipocytes generate heat using their numerous mitochondria and (Fig. 1d)
specialized thermogenic gene expression profile. When glucose is insufficient, then
either BAT intracellular TAG stores, gluconeogenesis, and circulating lipids released by
WAT fuel are capable of fueling BAT thermogenesis (Labbé et al., 2015). In brief, fatty
acids and glucose are usually used to generate ATP; however, BAT cells produce
uncoupling-protein 1 (UCP1) which creates a mitochondrial protein leak that dissipates
heat (Fedorenko, Lishko, & Kirichok, 2012). This heat production by BAT is increased
during cold exposure, becomes more efficient and robust when animals are chronically
exposed to cold, and is triggered by SNS activity (Festuccia, Blanchard, Richard, &
Deshaies, 2010). Astonishingly, BAT itself contributes to approximately one half of all
energy expended by cold-acclimated small rodents despite comprising less than one
percent of total body mass (Cannon & Nedergaard, 2004a). In obese rodents and
humans, BAT is less active and has a lower capacity for cold-induced activity than lean
counterparts (Lidell & Enerback, 2010). This demonstrates that reduced BAT function is
either caused by or contributes to the development of obesity. Therapeutic intervention
by enhancing BAT function may therefore prevent or reverse obesity development by
improving metabolic health in individuals at risk.
Results from studies using transplantation of BAT into BAT-deficient rodent
models tests the potential for non-native BAT to rescue rodent models of obesity and
glucose-intolerance. Autologous BAT transplant into the visceral cavity restores glucose
sensitivity in streptozotocin-induced diabetic mice, suggesting that BAT glucose
utilization is sufficiently high to rescue pancreatic islet cell destruction (Gunawardana &
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Piston, 2012). To illustrate the potentially versatile benefits of enhanced BAT function,
BAT implantation also rescues menstrual irregularity in rodent models of polycystic
ovarian syndrome (Yuan et al., 2016). These data together illustrate that a greater
amount of BAT, and theoretically enhanced activity of native BAT, may improve
dysregulated functions across several organ systems. Sympathomimetics that increase
BAT activity in rodents have little to no effect in humans (Cypess et al., 2012). However,
recent advances in BAT transplantation methodology (Tharp et al., 2015) established
that human BAT transplantation is approaching a clinical possibility.
Inspired by the advantages of targeting BAT to achieve better metabolic health,
many researchers are using this strategy to enhance the BAT-like functional
characteristics of WAT: known colloquially as ‘browning’ or ‘beiging.’ Indeed, some
WAT adipocytes are capable of transitioning from a lipid storage cell across an adipocyte
continuum to instead burn lipid by the induction of a somewhat brown or ‘beige’ state, a
transition brought on almost exclusively by chronic stimulation by the sympathetic
nervous system (SNS) (Cannon & Nedergaard, 2004a). Not all WAT adipocytes are
capable of browning, and importantly, beige adipocytes are not identical to classical
brown adipocytes most notably due to their divergence from different cell lineages (Wu
et al., 2012). These distinctions, however, do not prevent browned WAT depots from
generating measureable heat during cold exposure and thereby contribute to enhanced
energy expenditure when stimulated (Wu, Cohen, & Spiegelman, 2013). Thus, WAT
browning is poised to mediate obesity reversal by both generating heat to expend
energy, and by reducing the amount of classical WAT mass (Ishibashi & Seale, 2010).
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1.2.2 White adipose tissue (WAT) physiology
Classical WAT adipocytes store large vacuoles of lipid as TAG and have relatively
few mitochondria (Figure 1a). In addition to its role as a secretory organ (Scherer,
2006), a primary function of this tissue is to store excess lipid during periods of energy
surplus and release lipid as fuel during periods of energy deficit. During energy surplus,
WAT accumulates lipid by hypertrophy (i.e. growing in size) and by hyperplasia (i.e.
becoming more numerous in cell number) to accommodate more TAG (Bourgeois,
Alexiu, & Lemonnier, 1983). In rodents, WAT depots are stored in five stereotypically
identified regions (Fig. 1c) with three being subcutaneous (e.g. dorsal, inguinal), others
abdominal (e.g. perigonadal, retroperitoneal) and one visceral fat pad (e.g. mesenteric)
defined by its venous draining directly into hepatic portal circulation (Tchkonia et al.,
2013). Humans, however, store subcutaneous fat more homogeneously across the body
and, in the case of visceral obesity, have a large visceral omental fat depot under the
greater curvature of the stomach (Tchkonia et al., 2013). In rodents, individual control
of WAT depot size is accomplished by direct SNS outflow capable of delivering NE to
distinct depots in differential degrees (Brito, Brito, Baro, Song, & Bartness, 2007; Brito,
Brito, & Bartness, 2008).
Indeed, stimulated WAT lipolysis and BAT thermogenesis are triggered by SNS
stimulation. This notion is supported by broad expression of α1, 2 and β1, 2, 3 adrenergic
receptors (β-ARs) on adipocytes (Lafontan & Berlan, 1993), NE content within the
tissue, and ex vivo responses of cultured adipocytes to NE. WAT lipolysis is stimulated
when norepinephrine released by axon terminals of post ganglionic SNS neurons binds
to β-adrenoreceptors (β-ARs)—present on adipocytes (Lafontan et al., 1997)—initiating
a lipolytic cascade that is dependent on the phosphorylation of hormone sensitive lipase
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(HSL) leading to the preferential release of long-chain free-fatty acids (FFAs) and
glycerol from TAG stores (Bartness & Song, 2007a; Belfrage, Fredrikson, Nilsson, &
Stralfors, 1981). WAT lipid droplets contain an array of saturated and unsaturated
species of fatty acids in the form of TAG, spanning from characteristically short to long
carbon chain species (Raclot, Mioskowski, Bach, & Groscolas, 1995). Although all FFAs
are released during WAT lipolysis, polyunsaturated fatty acids with longer carbon
chains are mobilized to a higher degree (Raclot & Groscolas, 1993). Direct efferent
innervation of the tissue, instead of circulating NE, is thought to stimulate WAT lipolysis
and BAT thermogenesis because of the preserved SNS control of these functions after
adrenalectomy (Edens, Moshirfar, Potter, Fried, & Castonguay, 1999; Holt, Wheal, &
York, 1988).
1.3 Communication from adipose tissue to the brain
Adipose communication by neurohumoral factors was first described directly
with the discovery of leptin (Zhang et al., 1994); however more recent studies also define
an additional robust and interconnected sensory neural component of this tissue
(Bartness, Liu, Shrestha, & Ryu, 2014a; Giordano, Morroni, Santone, Marchesi, & Cinti,
1996). Adipose sensory nerve activity is an emerging contributor to blood pressure
regulation and likely other metabolic processes via broadly triggering SNS activation
(Niijima, 1998), this is despite any demonstration that WAT or BAT can generate signals
that communicate to the sensory nerves innervating the tissue. Because of the potential
for sensory innervation of WAT and BAT to affect SNS outflow, uncovering mechanisms
by which WAT and BAT activate their afferents may reveal key strategies for how
adipocyte function is integrated with many organ systems.
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To assess candidate activators of adipose afferents and targets of endocrine
communication, we begin with listing the probable types of messages fat may be sending
regarding its state and functions. WAT and BAT activity can be generally refined to
several distinct roles such that identifying these basic functions makes clear several
likely outgoing messages from fat to adipose afferents. 1) Lipogenesis is a crucial
ongoing process to animal survival preparing for unforeseen physiological challenges
(e.g. cold exposure, periods of famine); 2) Lipolysis is the breakdown and release of lipid
as fuel, which is rapidly triggered when glucose is insufficient and energy demand is
high; 3) BAT and ‘browned’ WAT thermogenesis also is a context-dependent rapidly
triggered process that is vital to rodent survival in a cold environment. These three
general functions of WAT and BAT occur during specific physiological states wherein
lipolysis and thermogenesis are high during energy challenge; lipogenesis occurs
primarily during energy surplus. Consequently, lipolysis and thermogenesis are vital to
survival during scarcity of food and warmth whereas lipogenesis occurs largely during
abundance of food and states of rest (Ng, 1990). It is unclear, however, if or how the
state of these adipose processes are signaled to other organs; but by the nature of their
design, endocrine signaling likely favors tonic messages while local paracrine fat to
neural signaling most likely favors acutely relevant adipocyte functions.
1.3.1 Circulating factors as adipose communication
Signaling polyproteins secreted by adipocytes, or adipokines, are a diverse pool of
molecules and contribute to a wide variety of physiological processes including but not
limited to energy expenditure, insulin sensitivity (Dyck, Heigenhauser, & Bruce, 2006;
Mullen et al., 2009), cardiovascular function (Salazar et al., 2016), immune function
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(Odegaard & Chawla, 2013), hunger, and even reproduction (Reverchon, Ram, Bertoldo,
& Dupont, 2014). Among the over hundreds of adipokines identified (Halberg,
Wernstedt-Asterholm, & Scherer, 2008; Scherer, 2006), leptin and adiponectin are
perhaps the most highly studied. Leptin is secreted by fat based on the amount of
accumulated lipid evidenced by serum levels proportional to the amount of stored WAT.
It is colloquially referred to as the ‘adiposity hormone.’ Adiponectin, which is present in
serum inversely proportional to fat mass, precedes insulin insensitivity by its
diminished levels in blood (Lee & Shao, 2014). As with other adipokines, leptin exerts its
effects at many targets (e.g. brain, peripheral nervous system, liver, bone, heart,
gastrointestinal tract) and is thought to inform the body of the general amount of
adipose tissue. Mechanisms of leptin resistance, a term that describes the insufficiency
for exogenous leptin to inhibit appetite and reduce body mass in the case of dietinduced obesity, are sought after by many and believed to be driven by leptin receptor
sensitization, downregulation, and/or diminished permeability of leptin into the brains
of obese animals. However, leptin resistance as a phenomenon may be misguided due to
the apparent hyperphagia induced by leptin absence compared with little to no effect on
feeding after exogenous administration and/or exaggerated levels during an obese state
(Allison & Myers, 2014). A more reasonable explanation is the impaired functioning of
downstream signaling in metabolic neuronal populations because of enhanced
suppressor of cytokine 3 or an otherwise enhanced inflammatory profile (Myers, 2015).
Clearly, leptin as well as adipokines are examples of adipocytes signaling to other tissues
and can become dysregulated during disease conditions (e.g. obesity and diabetes).

11

1.3.2 Peripheral innervation of adipose tissue
In addition to endocrine signaling by adipokines, it is clear that local paracrine
communication between adipocytes and neurons within fat depots occurs on a rapid
scale. Efferent, or motor, innervation of fat was clearly defined with the first observance
of direct efferent connectivity in 1898 by Dogiel (Dogiel, 1898), and many have
demonstrated functional integration of SNS into fat tissue (for review see (Bartness et
al., 2014a). Afferent, sensory innervation of fat, however, was not anatomically
identified until 1987 by Fishman and Dark (Fishman & Dark, 1987) and has been
studied to a relatively underwhelming degree.
1.3.2.1 Sensory nerve phenotype
First identified using the true blue neurotracer directly into WAT (Fishman &
Dark, 1987), WAT and BAT afferents share a common neurochemical profile with
nociceptive free nerve endings throughout the body. Immunohistochemical
identification of WAT afferents in the tissue reveals expression of sensory nerve markers
calcitonin-gene related peptide (CGRP) and substance P indicating the presence—or the
absence—of sensory innervation (Giordano et al., 1996). Electron microscopy of WAT
afferents using these markers reveals a mix of both myelinated and unmyelinated fibers
that are congregated predominately around vasculature of the innervated tissue (De,
Ricquier, & Cinti, 1998).
These afferents, like other afferents innervating skin, muscle, and liver, are
pseudo-unipolar neurons , with a single axon bifurcating where one arm extends to the
sensory organ and the other arm projecting into the spinal cord to synapse with dorsal
horn neurons at the level of spinal entry (Tandrup, 1995). Tracing studies suggest that
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WAT and BAT afferents are spinal neurons, in that their cell bodies are located together
among a group of cell bodies outside the spinal cord known collectively as the dorsal
root ganglion (DRG) (Fishman & Dark, 1987). To understand the functional roles of
WAT sensory innervation, DRGs are extracted post-mortem to characterize neurotraced adipose afferents using immunohistochemistry (Murphy et al., 2013) and in situ
hybridization (Oliveira et al., 2003). DRG analysis of WAT afferent nerves is often
preferred to tissue level analysis due to cell body access and possible occlusion of
afferent fibers by adipocytes that make distinguishing WAT from afferent nerve receptor
protein expression difficult; further, immediate early genes (e.g. c-Fos, pERK) are
common proxies for neuronal activity and are only present in cell bodies (Hoffman,
Smith, & Verbalis, 1993). Using this method together with immunohistochemistry for
the long form leptin receptors (ObRb), we have demonstrated that WAT afferents are
activated by injection of leptin into WAT (Murphy et al., 2013). Functional evidence
described in depth below also suggests that WAT afferents express adenosine receptors
and capsaicin-sensitive transient potential vallinoid receptors (TrpVRs) (Shi et al.,
2012).
1.3.2.2 Motor nerve phenotype
As with other SNS fibers that send output to organs (e.g. liver, pancreas, heart),
WAT efferent/motor nerves are neurochemically homogenous in that most are
identified by catecholaminergic markers (e.g. dopamine β-hydroxylase, tyrosine
hydroxylase) and neuropeptide Y (NPY). Transneuronal viral neurotracing of WAT
reveals broad neuronal populations in brain and spinal regions discussed in detail
below; however, neurotracing to WAT pads whose catecholaminergic innervation has
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been depleted by a SNS-specific neurotoxin—6-hydroxy-dopamine—results in no
apparent innervation across the peripheral and central neuraxis (Giordano et al., 2006).
The finding that parasympathetic nervous system (PSNS) innervation of fat has been
described as well (Kreier et al., 2002). This is controversial, however, because classical
markers of PSNS are not present in adipose tissue (Ballantyne, 1968; Giordano et al.,
2006). Thus, evidence that adipose motor nerves are entirely catecholaminergic suggest
that PSNS innervation is trivial at best (Giordano et al., 2005; Giordano et al., 2007;
Lundberg, Terenius, Hokfelt, & Goldstein, 1983).
Control of SNS WAT and BAT efferent nerves drives lipolysis and thermogenesis
of WAT and BAT, respectively (Bartness et al., 2014a); therefore, mechanisms of WAT
and BAT efferent control are those which coincide with energy expenditure to a large
degree. Although many attempts have been made to pharmacologically mimic SNS
output to promote fat loss in humans (Omran, 2016), most therapies include
concomitantly increased cardiovascular risk (Siebenhofer et al., 2016). To this end,
specific SNS activation of adipose efferents is a primary goal to achieve safe obesity
reversal in humans.
1.3.3 Central innervation of adipose tissue
We have established efferent and afferent neural circuits of BAT and WAT by
using transneuronal viral tract tracers (Bamshad, Song, & Bartness, 1999; Bartness,
Song, Shi, Bowers, & Foster, 2005; Bowers et al., 2004; Ryu, Garretson, Liu, Vaughan, &
Bartness, 2015b; Song, Schwartz, & Bartness, 2009). These methods rely on infection of
neural tissue after parenchymal viral injection into single or multiple tissue depots.
Bartha K Pseudorabies virus strains (PRV) that express green (PRV152) or red (PRV614)
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fluorescent proteins specifically infect neurons from the ends of their circuit to the
beginning, infecting neuronal pathways in a retrograde fashion with viral uptake
occurring at the nerve terminals (Strack & Loewy, 1990). These two viruses have been
used to trace differences in efferent innervation between multiple fat pads (Nguyen,
Randall, Banfield, & Bartness, 2014) and elucidated shared and divergent neural
pathways to individual depots. Herpes simplex virus strain 129 (HSV129) infects
neuronal pathways in an anterograde fashion (Barnett, Evans, Sun, Perlman, & Cassell,
1995), traveling from the beginning of neural circuits to the end with viral uptake
occurring at dendritic processes. Viral infection of PRVs and HSV129 occurs when viral
attachment molecules bind to neuronal glycoproteins. These are amplified by the
infected cells, and then transmitted to connected neurons (Curanovic & Enquist, 2009;
Ekstrand, Enquist, & Pomeranz, 2008). Although PRVs and H129 seem to infect all first
order neurons despite their role as sensory or motor neurons in the tissue (Rinaman &
Schwartz, 2004), viral transmission to the next neuron in the circuit occurs via distinct
differences in their axonal transport and synaptic transmission. Therefore, these viruses
have been key tools to illustrate the central efferent and afferent neural circuits
connected to adipose tissue.
Using both PRV152 and HSV129 in the same animal, we have illustrated
individual neurons that both receive sensory input from and project SNS outflow to
WAT (Bartness & Song, 2007b) and to BAT (Ryu et al., 2015b). These double labeled
neurons throughout the neuraxis are presumably each capable of relaying sensory input
from fat into SNS outflow to fat. We find that most double-labeled neurons reside in the
mid and hindbrain (Bartness et al., 2014a). Based on the accumulating evidence that
WAT afferent activation increases in SNS activity (Li et al., 2013; Niijima, 1998), these
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relay neurons likely propagate a feed-forward WAT-brain-SNS circuit meaning afferent
activation leads to efferent activation. Indeed, adipose-initiated SNS reflexes that do not
require cortical function are supported by the neuroanatomical localization of midbrain
and brainstem WAT-BAT circuits sufficient to drive BAT thermogenesis in the absence
of neural connectivity with structures rostral to the midbrain. For example, cooling of
the skin increases BAT thermogenesis in decorticated but not decerebrated rats (Osaka,
2004), a reflex action believed to originate by BAT afferent activation.
1.4 Sensation and functions of adipose afferent nerves inferred by
denervation experiments
WAT and BAT afferents have been demonstrated to contribute to distinct
biological functions such as SNS feedback regulation to multiple tissues (Niijima, 1998,
1999), SNS-induced hypertension (Xiong, Chen, & Zhu, 2014), regulation of fat
deposition throughout the body (Shi & Bartness, 2005), and food intake regulation
(Yamada et al., 2006). These functions have been elucidated by two primary approaches
to date. First, loss of function experiments using surgical denervation or excitotoxic
chemical denervation by high dose capsaicin (Jancso et al., 1984) or resinerfertoxin
(Acs, Biro, Acs, Modarres, & Blumberg, 1997) infused into adipose tissue of anesthetized
rodents. The second approach to test WAT and BAT afferent function is accomplished
by recording extracellular neurophysiological activity in anesthetized animals beginning
with Niijima’s discovery that leptin activates WAT afferents (Niijima, 1999) and more
recently with understanding mechanisms of the adipose afferent reflex (AAR) (Shi et al.,
2012; Xiong et al., 2012; Xiong et al., 2014). This section will discuss technical details of
these approaches as well as their advantages and disadvantages to interrogate adipose
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afferent neurophysiological stimulators and physiological processes engaged by
increased adipose afferent activity.
1.4.1 Technical approaches to denervation
Surgical or chemical destruction of peripheral nerves innervating tissues are
exclusion experiments designed to test the role of neural connectivity by categorically
comparing intact with denervated animals to infer chronic neural function. These
experiments, although quite useful for establishing necessity of WAT and BAT afferent
connectivity, have two critical flaws in that both 1) lack specificity and 2) rely on a
surgical recovery period of weeks during which some degree of reinnervation of the
tissue and/or other physiological compensation will likely occur. Both surgical and
chemical methods consistently reduce or abolish sensory nerve markers (e.g. substance
P, CGRP) within fat tissue compared with control animals suggesting that despite these
shortcomings each technique is adequate for testing the necessity of WAT and BAT
afferent functions. Tissues that are specifically targeted by these methods are the
interscapular BAT, perigonadal (GWAT), or the subcutaneous inguinal WAT (IWAT).
Whole animal deafferentation by capsaicin, although non-specific to adipose afferents,
is relevant to this discussion and will be referenced in regard to adipose functions
controlled by afferents.
Surgical denervation of WAT and BAT is completed by physically removing a
portion of all nerves innervating each tissue, which prevents adipose tissue from
emitting sensory neural signals (Vaughan, Zarebidaki, Ehlen, & Bartness, 2014). During
this procedure, a small section of each nerve is removed using two precise cuts—
instead—of a single cut to reduce the likelihood of nerve regrowth by a neural system
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unknown in its regenerative capacity. This type of denervation is performed while the
animal is anesthetized, typically takes 2-3 min per fat pad, has only been completed in
rodents. To successfully accomplish this task and completely destroy all innervation of
the target fat pad, the surgeon must non-specifically destroy nerves innervating
overlaying skin—subcutaneous fat—or nearby organs possibly innervated by shared
nerve bundles. The nonspecific denervation of other organs more likely occurs with
GWAT surgical denervation compared with IWAT and IBAT due to their relative
proximities to other organs (e.g. gonads) (Cinti, 1999). By definition, surgical
denervation mutes bidirectional communication of both sensory signals arising from fat
and, importantly, motor signals communicated by the brain to fat. Thus, despite surgical
denervation being the most complete method to abolish adipose sensory signals, its
equal removal of SNS outflow to fat often excludes it as an independent tool to
investigate the role of sensory specific innervation. Consequently, surgical denervation
is often accompanied with more chemically specific approaches when adipose afferent
function is considered.
Chemical denervation by high doses of capsaicin (Jancso et al., 1984) or
resinerfertoxin (Acs et al., 1997) infusion into fat involves controlled surgical
microinjections throughout the target tissue (Vaughan et al., 2014) to cause
excitotoxicity of sensory neurons specifically. During this procedure, sub-microliter
volumes of fluid are infused into as many as 20 loci across the entire fat pad to produce
the most robust decreases in sensory innervation—as measured by CGRP protein
content in homogenized tissue 3-6 weeks after recovery (Vaughan & Bartness, 2012).
For each locus of injection, the microsyringe needle is held in place for 1 min to
minimize efflux of fluid outside the pad and reduce the spread to non-specific tissues;
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thus this surgery takes up to 20 min per fat pad and therefore requires a considerably
longer duration of anesthesia than with surgical denervation. Due to the duration of
time spent injecting the fat pad and the surgical recovery period thereafter, acute
conclusions from adipose afferent destruction studies are often avoided.
The most profound flaw of chemical denervation is that it does not completely
abolish sensory innervation within the tissue. Typically, successful chemical denervation
results in a reduction in total CGRP protein of as little as ~40-50% less than vehicleinjected control tissues (Vaughan & Bartness, 2012). This is either due to the excitotoxin
not reaching all adipose afferents in the fat pad or that both capsaicin and
resinerfertoxin target transient receptor potential cation channel subfamily V member 1
(TrpV1) receptors which may be present on some but not all CGRP-positive sensory
neurons (Koltzenburg, 2004). Although this sensory nerve destruction is clearly not as
complete as surgical destruction of afferents, its specificity to sensory not motor neurons
is paramount. The physiological effects it produces marks this as the most useful tool to
test metabolic processes that require functionally intact adipose afferents.
1.4.2 Adipose afferent sensation and function inferred by denervation
experiments
These loss of function studies describe the variety of physiological functions that
required adipose afferent innervation. Surgical removal of fat from one specific depot
causes increased lipid accumulation in other fat depots, we demonstrated that this
compensation exists in Siberian hamsters (Mauer & Bartness, 1994). It also can be
mimicked by WAT afferent chemical destruction (Shi, Song, Giordano, Cinti, &
Bartness, 2005), suggesting that WAT afferents provide ‘inventory’ data to the CNS
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which then compensates for the loss of fat by adding more elsewhere (Mauer, Harris, &
Bartness, 2001). In addition, chemical denervation of IWAT or EWAT afferents
contributes to a regulation of fat cell proliferation (Shi et al., 2005).
General connectivity between WAT afferents and BAT has been investigated
following chemical deafferentation of rats by systemic capsaicin (Cui & Himms-Hagen,
1992a; Cui, Zaror-Behrens, & Himms-Hagen, 1990; Melnyk & Himms-Hagen, 1994).
After systemic capsaicin treatment, rats have diminished BAT thermogenic capacity
(Giordano et al., 1998) and atrophy of the IBAT tissue depot (Cui & Himms-Hagen,
1992b; Cui et al., 1990). These studies suggest that afferent nerve throughout the body
functionality contributes to healthy BAT function and provokes curiosity into the
specific location of the afferents that control of BAT.
Only one study demonstrates that adipose afferents exert effects on the
innervated tissue by the local release of neuropeptides. This signaling mechanism is well
defined in other innervated tissues [e.g. muscle (Dvorakova, Kruzliak, & Rabkin, 2014)]
but otherwise novel to adipocyte afferent innervation. CGRP released by BAT afferent
nerves reduces sensitivity of BAT adipocytes to NE thus attenuating SNS-induced
thermogenesis (Osaka et al., 1998). Neuropeptide release by WAT afferents may
perform similar functions although this has yet to be investigated. As a potent
vasodilator (Tippins, 1986), CGRP’s release by adipose afferents may increase adipose
blood flow to enhance the reception or extravasation of lipid by the adipose organs.
1.4.3 Technical approach to neurophysiological recordings
Extracellular nerve recordings of adipose innervation are a targeted surgical
approach to test for the control of afferent or efferent function of these nerves in an
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anesthetized rodent. To date, adipose afferent recordings have only been accomplished
in rats and Siberian hamsters, the former due to their larger relative size and the latter
because of the detailed illustrations of adipose innervation revealed by tract tracing
studies (Bamshad et al., 1999; Bartness et al., 2005; Bowers et al., 2004; Ryu et al.,
2015b; Song et al., 2009). Critical to this technique is effective surgical isolation of
anatomically connected nerves innervating the tissue and electrical isolation of the
desired signal (i.e. afferent or efferent). When examining adipose afferent function, this
technique involves infusing the target fat depot with a candidate chemical to test for the
sufficiency to activate sensory fibers monitored by the recording electrode. Each of these
strategies, however, must be performed under urethane or ketamine/xylazine
anesthesia wherein the rodents’ temperature regulation, metabolic rate, respiration, and
blood pressure are all unlike that of an awake animal. Because of these limitations,
experiments using this method explicitly exclude behavioral measures and perhaps are
solely capable to identify acute perturbations that mechanistically control adipose
afferents and efferent activity.
1.4.4 Adipose afferent sensation and function demonstrated by
neurophysiological recording experiments
Niijima was the first to demonstrate experimental activation of WAT afferents by
measuring increased afferent spiking after leptin infusion into epididymal WAT
(GWAT) (Niijima, 1998). Adipose activation induced by leptin is repeated in a series of
studies (Niijima, 1998, 1999; Shi et al., 2012), it occurs within minutes after the onset of
infusion, and is also apparent in neurons arising from inguinal WAT (Murphy et al.,
2013; Shi et al., 2012; Xiong et al., 2012; Xiong et al., 2014). In addition, Niijima was the
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first to demonstrate that neurophysiological recordings of adipose nerves was possible,
and served as the principal exploration into a new method by which WAT afferent
sensitivity can be established. Niijima further discovered leptin-induced GWAT afferent
activation reflexively increases in SNS outflow to GWAT and broadly dampens vagal
nerve PSNS outflow (Niijima, 1999), also serving as the first identification that efferent
outflow could by triggered by WAT afferent activation.
WAT afferent-induced SNS outflow, later termed the ‘adipose afferent reflex’
(AAR), has been extended by Zhu and colleagues into an apparent sufficiency of IWAT
afferent activity to trigger renal SNS outflow thereby increasing blood pressure. This
positive reflex is initiated by IWAT activation which can be induced by leptin but also by
bradykinin, adenosine, and the indiscriminate activator of sensory nerves, capsaicin.
The WAT afferent activators not included by Niijima (e.g. bradykinin, adenosine)
further extend the role of WAT afferents to monitor the release of a variety of ligands
from adipocytes and implicate WAT afferents in organ systems. Overall, Zhu and
colleagues argue that WAT afferents sensitive to leptin are involved in SNS increases
causing hypertension. This positive feedback may be responsible for the high
comorbidity between obesity and hypertension in humans. Adenosine receptors A1 and
A2 on adipocytes regulate fat lipolysis as well (Johansson, Lindgren, Yang, Herling, &
Fredholm, 2008); thus, sensation of adenosine by WAT afferents vaguely suggests
lipolysis is an event that stimulates their activity. Bradykinin, however, is primarily
released by the kidneys in response to increased blood pressure and therefore may serve
as a message to WAT afferents regarding the status of circulation. Thus, this serves as a
conduit that is important to adipose tissue for released lipolytic products to be
circulated throughout the body as fuel. Overall, WAT afferent activation causes
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increases in SNS outflow to multiple targets and these data highlight this neural circuit
as mediator of SNS function overall.
Despite the broad and seemingly redundant distribution of adipose afferent and
efferent neural circuitry (Bartness & Song, 2007c; Song et al., 2009), the paraventricular
nucleus of the hypothalamus (PVH) is a required brain region through which WAT
afferent-induced hypertension occurs. Excitotoxic lesion of the PVH disrupts the AAR
by attenuating increased renal SNS activity (Cui et al., 2013). Several lines of evidence
have been proposed for the mechanism by which the PVH converts adipose afferent
stimulation to SNS outflow. Indeed, blockade of PVH melanocortin 3 and 4 receptors
produces similar AAR inhibition as PVH lesion, as also is the case for GABAa receptor
antagonism (Ding et al., 2015a) and depletion of PVH supraoxide anions by the
scavenger tempol (Ding et al., 2013). All of these explorations of the PVH involvement
use capsaicin infusions into IWAT or GWAT as an AAR trigger which increases PVH
field potentials; however, it is unclear if PVH disruption by any of these means prevents
excited adipose afferents from causing SNS increases, or if central disruption of this
pathway reduces excitability of adipose afferents by capsaicin. This shortcoming
demonstrates fundamental questions that still exist in adipose afferent physiology
because of the difficulty to capture the synchrony of organ systems using techniques
currently available.
The apparent increased SNS outflow has been of key interest among labs
studying adipose afferent physiology; however, only we have produced a physiological
challenge for the animal and measured subsequent adipose afferent responses (Song et
al., 2009). Peripheral administration of 2-deoxy-glucose (2DG), a sympathomimetic
that causes the β-adrenergic dependent breakdown of adipose tissue, also causes a
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correlational increase in WAT afferent activity suggesting again that lipolysis, as also
hinted by direct adenosine infusion into IWAT, causes WAT afferent stimulation. This
suggests either that adipose afferents are stimulated by circulating products of lipolysis
(e.g. FFAs and glycerol) or that they sense local secretions by their receptive fields
within fat parenchyma. In order to dissociate these two possibilities, improved methods
are needed to site specifically cause lipolysis and capture site specific afferent responses.
1.5 Purpose of this dissertation
After synthesis of the known characteristics of adipose afferents and their
downstream functions, many inferences suggest activation by and interconnectedness of
these fibers with other organ systems. Adipose afferents potentially control body fat
deposition, general SNS outflow, and do so by their collective patterns of nerve activity
that somehow drive coordinated organ level responses. Of the evidence provided, the
research themes by others are focused on SNS-outflow produced by general adipose
afferent activation; however, it is largely unclear under what physiological settings these
nerves are activated. Indeed, correlational exploration of glucoprivation-induced
afferent activation is the only study that demonstrates adipose afferents respond to
adipocyte-derived signals based on a physiological reaction to enhanced SNS drive
(Song et al., 2009). Instead, others have injected exogenous substances into WAT or
BAT as in vivo pharmacological experiments by testing the capability of their ligand of
choice to affect the adipose afferents hidden within the depot. To this effect, injecting
leptin into WAT—at a dose not justified to be physiologically relevant—to stimulate
WAT afferents ignores the context in which adipocytes may release leptin to activate
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these afferents in vivo. These tests essentially neglect the notion that specific functions
of adipocytes cause afferent activation.
Thus, we seek to understand what signals BAT and WAT adipocytes are capable
of producing that control the activity of the afferent nerves residing within. We
accomplish this by testing the hypothesis that SNS-outflow to BAT and WAT results in
increased adipose afferent nerve activity; specifically, BAT afferents are thermosensors
and WAT afferents are lipid sensors. We do so by using the β3-AR agonist CL 316,243 to
target adipocytes within each depot then measuring subsequent reactions of BAT and
WAT afferents. Measurements of afferent activity include neurophysiological recordings
and neurotracing combined with c-Fos immunohistochemistry as a molecular marker of
activation within connected DRGs. We continue this work by demonstrating
neuroanatomical feedback loops comprised of BAT sensory and sympathetic nerves
using transneuronal viral tract tracing. In addition, we establish a functional neural
connection between WAT and BAT whereby WAT afferent activity drives BAT
thermogenesis. Finally, we explore a novel chemogenetic strategy that permits
measurement of the behavioral and metabolic consequences of adipose afferent activity
in awake-behaving animals for the first time. Progress in developing this approach is
discussed and additionally, we propose improvements based on this work for future
studies.

25

Copyright by
The Journal Neuroscience
2015

26

2

BROWN ADIPOSE TISSUE HAS SYMPATHETIC-SENSORY
FEEDBACK CIRCUITS

Vitaly Ryu, John T. Garretson, Yang Liu, Cheryl H. Vaughan, and Timothy J. Bartness

Department of Biology, Center for Obesity Reversal, Neuroscience Institute, Georgia
State University, Atlanta, Georgia, 30302-4010

Published in The Journal of Neuroscience on February 4th 2015

2.1 Abstract
Brown adipose tissue (BAT) is an important source of thermogenesis which is
nearly exclusively dependent on its sympathetic nervous system (SNS) innervation. We
previously demonstrated the SNS outflow from brain to BAT using the retrograde SNSspecific transneuronal viral tract tracer, pseudorabies virus (PRV152) and demonstrated
the sensory system (SS) inflow from BAT to brain using the anterograde SS-specific
transneuronal viral tract tracer, H129 strain of herpes simplex virus-1. Several brain
areas were part of both the SNS outflow to, and receive SS inflow from, interscapular
BAT (IBAT) in these separate studies suggesting SNS-SS feedback loops. Therefore, we
tested whether individual neurons participated in SNS-SS crosstalk by injecting both
PRV152 and H129 into IBAT of Siberian hamsters. To define which dorsal root ganglia
(DRG) are activated by BAT SNS stimulation, indicated by c-Fos immunoreactivity (ir),
we pre-labeled IBAT DRG innervating neurons by injecting the retrograde tracer Fast
Blue (FB) followed 1 wk later by intra-BAT injections of the specific β3-adrenoceptor

27

agonist CL316,243 in one pad and the vehicle in the contralateral pad. There were
PRV152+H129 dually-infected neurons across the neuroaxis with highest densities in
the raphe pallidus nucleus, nucleus of the solitary tract, periaqueductal gray,
hypothalamic paraventricular nucleus and medial preoptic area, sites strongly
implicated in the control of BAT thermogenesis. CL316,243 significantly increased IBAT
temperature, afferent nerve activity and c-Fos-ir in C2-C4 DRG neurons ipsilateral to
the CL316,243 injections versus the contralateral side. The neuroanatomical reality of
the SNS-SS feedback loops suggests coordinated and/or multiple redundant control of
BAT thermogenesis.
2.2 Introduction
Brown adipose tissue (BAT) is a critical for non-shivering thermogenesis in
rodents and its physiological function is directly controlled by its sympathetic nervous
system (SNS) innervation (Bartness, Vaughan, & Song, 2010; Richard & Picard, 2011).
Rodent BAT has parasympathetic nervous system (PSNS) innervation of two minor BAT
depots -- pericardial (Schafer, Eiden, & Weihe, 1998) and mediastinal (Giordano,
Frontini, Castellucci, & Cinti, 2004), but not interscapular BAT (IBAT), the major
rodent BAT depot (Giordano et al., 2004). Absence of BAT PSNS permits use of the viral
transneuronal tracer pseudorabies virus (PRV; Bartha’s K strain) to define the origins of
the SNS outflow innervating peripheral tissues [for review see: (Enquist, 2002; Song,
Enquist, & Bartness, 2005)] including IBAT (Bamshad et al., 1999; Oldfield et al.,
2002). Increases in BAT SNS drive lead to release of norepinephrine (NE) from its SNS
postganglionic nerve terminals thereby stimulating brown adipocyte β3-adrenoceptors
[e.g., (Zhao, Unelius, Bengtsson, Cannon, & Nedergaard, 1994)] that ultimately activate
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uncoupling protein-1 resulting in thermogenesis increases [for review see: (Cannon &
Nedergaard, 2004b)]. This NE effect is mimicked by CL316,243, a highly selective β3adrenoceptor agonist both in vivo (Atgie, Faintrenie, Carpene, Bukowiecki, & Geloen,
1998a; Himms-Hagen et al., 1994) and in vitro (Gabaldón, McDonald, & Horwitz,
1998)
BAT also has sensory system (SS) innervation. At the tissue level, IBAT has
immunoreactivity (-ir) for two proven SS neuropeptides, substance P and calcitonin
gene-related peptide (De et al., 1998; Norman, Mukherjee, Symons, Jung, & Lever,
1988). Furthermore, with intra-IBAT injection of an anterograde transneuronal viral
tract tracer, the H129 strain of herpes simplex virus 1 (HSV-1), we identified the central
SS circuits from this tissue (Vaughan & Bartness, 2012). Many of the sites receiving SS
input from IBAT (Vaughan & Bartness, 2012) also are part of the SNS outflow from the
CNS to IBAT revealed by our PRV studies. Thus, this SNS-SS overlap between studies
suggests the possibility of individual neurons that are part of the SNS outflow from
brain to BAT that also receive SS input from the tissue – that is, potential SNS-SS
feedback loops serving an anatomical basis for crosstalk between BAT SNS and SS
innervations. Although the exact role of the BAT SS is unknown, the impairment of the
thermogenic response of BAT to acute cold exposure due to sensory denervation
accomplished via intra-IBAT injection of the sensory-specific neurotoxin capsaicin
(Jansco, Kiraly, & Jansco-Gabor, 1980; Jansco, Kiraly, Joo, Such, & Nagy, 1985),
strongly suggests BAT SS innervation is necessary for its optimal physiological
functioning (Vaughan & Bartness, 2012). Therefore, we hypothesized that BAT SNS-SS
feedback loops might exist and tested this as well as identifying which dorsal root
ganglia (DRG) receive sensory input when IBAT is adrenergically-activated by: 1)
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injecting both the SS-specific transneuronal tract tracer, H129, and the SNS-specific
transneuronal tract tracer, PRV, intra-IBAT to test for dually-infected SNS-SS neurons,
2) injecting CL316,243 intra-IBAT using c-Fos-ir to reveal activation (Hoffman et al.,
1993) of pseudounipolar neurons within the DRG pre-labeled with Fast Blue (FB)
thereby identifying IBAT afferent neurons activated by IBAT adrenergic stimulation,
and 3) measuring IBAT sensory nerve activity electrophysiologically after intra-IBAT
CL316,243 injection.
2.3 Methods and Materials
In this study we used Siberian hamsters (Phodopus sungorus) because these
animals provide an irreplaceable model over other rodent models to study a naturallyoccurring seasonal obesity as well as foraging and hoarding. Using this model, we
established the origins of the efferent sympathetic (SNS) outflow from brain to WAT
and BAT pads utilizing SNS-specific viral tract tracer PRV152. Moreover, we identified
the central sensory centers innervating those fat pads using sensory-specific viral tract
tracer H129 which altogether prepared neuroanatomical background for identification
of SNS-SS circuits to characterize specific fat pads.
2.3.1 Animals
Adult male Siberian hamsters (Phodopus sungorus; ~3-4 mo old) from our
breeding colony were single-housed in a long day photoperiod (16h:8h light:dark cycle;
at 22 ± 2 ºC) with free access to water and regular chow for 1 wk before viral injections.
All procedures were approved by the Georgia State University Institutional Animal Care
and Use Committee and are in accordance with Public Health Service and United States
Department of Agriculture guidelines.

30

2.3.2 Experiment 1: Viral injections
All virus injections were performed according to Biosafety Level 2 standards.
Hamsters (n=8) were anesthetized with isoflurane (2.0-3.0 % in oxygen; Baxter
Healthcare, Deerfield, IL) and the left IBAT pad was exposed for a series of PRV152 (gift
from Dr. Enquist, Princeton University) microinjections (7.5 x 107 pfu/ml) into five loci
(150 nl/locus) evenly distributed across one IBAT pad. After 24 h, the same IBAT pad
received five H129 (gift from Dr. Richard Dix, Georgia State University) microinjections
(7.5 x 107 pfu/ml; 150 nl/locus). The syringe was held in place for 60 s to prevent efflux
of virus after each injection. Finally, the incision was closed with sterile sutures and
wound clips. Nitrofurozone powder (nfz Puffer; Hess & Clark, Lexington, KY) was
applied locally to minimize the risk of bacterial infection. Note that previously we
demonstrated that surgical isolation of the fat pad from the surrounding tissues before
H129 injections results in a pattern of infection indistinguishable from that of pads
injected in their natural in situ position suggesting the infections came directly from
sensory nerves innervating the fat pad, but not the surrounding tissues [Song, C.K. and
Bartness, T.J., unpublished observations]. As a control for possible viral diffusion, we
also demonstrated that the same virus titer of PRV152 or of H129 and volume placed on
the surface of the exposed IBAT pad resulted in no infection in the sympathetic ganglia
or DRG, spinal cord, and brain as opposed to intra-IBAT pad viral infections (Ryu V and
Bartness TJ, unpublished observations). In addition, we found both PRV152 and H129infected neurons in the intermediolateral cell column (IML) of the spinal cords (data not
shown), respectively, suggesting specific IBAT-SNS ganglia and IBAT-SS DRG-spinal
cord-brain routes of infection which are in concordance with our previous findings
where PRV152 and H129 individually infected the classic SNS and SS spinal cord

31

neurons (Bamshad et al., 1999; Vaughan & Bartness, 2012). Finally, we have not noticed
left-right pad differences in brain infections with injections of either PRV152 or H129.
Note that pilot studies indicated no left-right IBAT differences (Vaughan, C.H. and
Bartness, T. J.; and Song, C. K. and Bartness, T. J., unpublished observations) nor in our
published work (Bamshad et al., 1999; Leitner & Bartness, 2009; Song et al., 2008;
Vaughan & Bartness, 2012).
2.3.3 Experiment 2: Fast Blue (FB) labeling and CL316,243
administration
One week before CL316,243 microinjections, Siberian hamsters (n=12) were
deeply anesthetized with ketamine/xylazine (100 mg/kg, 10 mg/kg; i.p.) and a dorsal 2
cm interscapular incision was made to expose IBAT. The retrograde tracer FB (1.0 %;
EMS-CHEMIE GmbH, Gross-Umstadt, Germany) was injected with a microsyringe into
five separate loci (1 µl/locus) of the left IBAT. After the last injection, the incision was
closed with sterile wound clips and ketofen [5 mg/kg; s.c.; Fort Dodge Animal Health,
Fort Dodge, IA] was administered for 3 d postinjection to minimize postoperative
discomfort.
For CL316,243 administration, two electronic transponders (Bio Medic Data
Systems Inc., Seaford, were connected to BAT-10 Thermometer Physitemp (Physitemp
Instruments Inc., Clifton, NJ). CL316,243 (0.2 ng/kg in 0.9 % saline), a highly selective
β3-adrenoceptor agonist that stimulates facultative thermogenesis [e.g., (Himms-Hagen
et al., 1994)], was injected intra-left IBAT at five loci (2 μl/locus for a total of 10 μl)
while nearly simultaneous intra-right IBAT injections of CL) each with a built-in
temperature sensor were gently implanted under each IBAT pad, the output of which
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was read with a hand-held DAS-7007R scanner (Bio Medic Data Systems Inc.) for IBAT
temperature (TIBAT) acquisition as we have used successfully previously (Brito et al.,
2007; Leitner & Bartness, 2009; Nautiyal et al., 2008; Song et al., 2008; Vaughan &
Bartness, 2012; Vaughan, Shrestha, & Bartness, 2011). This system provides an
opportunity to program the transponder with a unique identification code to distinguish
between left and right IBAT pad temperatures. Core body temperature (Tb) in these
anesthetized animals was measured using a rectal temperature sensor. The saline
vehicle (2 μl/locus for a total of 10 μl) served as a within animal control. In preliminary
studies, we determined that s.c. CL316,243 injections at 0.2 ng/kg failed to elevate TIBAT
and therefore this dose was selected for IBAT microinjections [Ryu, V. and Bartness,
T.J., unpublished observations]. Following each injection, the microsyringe needle was
held in place for at least 1 min to minimize efflux. The incision was immediately closed
with sterile wound clips and parallel temperature recordings from both IBAT pads as
well as Tb were monitored every 5 min for 1 h post injection (observation time based on
pilot studies showing little or, most often, no change in temperatures after that time
[Ryu, V. and Bartness, T. J., unpublished observations).
2.3.3.1 Histology
Animals were terminated 6 d after the last PRV152 injections (5 d after the last
H129 injections) based on progression of both viruses to the brain in pilot studies (Ryu,
V. and Bartness, T. J, unpublished observations). Hamsters were overdosed with
pentobarbital sodium (Sleep Away; 300 mg/kg) and transcardially perfused with 0.9 %
heparinized saline followed by 4.0 % paraformaldehyde in 0.1 M phosphate buffered
saline (PBS; pH 7.4). The brains were collected and post-fixed in the same fixative for 3-
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4 h at 4 °C, then transferred to a 30.0 % sucrose solution in 0.1 M PBS with 0.1 %
sodium azide and stored at 4 °C until they were sectioned on a freezing stage sliding
microtome at 30 μm. Sections were stored in 0.1 M PBS solution with 0.1 % sodium
azide until processed for double immunofluorescence.
For the CL316,243 experiment, the hamsters were euthanized with pentobarbital
sodium (Sleep Away; 300 mg/kg) immediately after individual temperature recordings
and transcardially perfused (see above). DRG associated with vertebral levels C1-T5
were extracted bilaterally, the epineurium debrided from the ganglia, post-fixed in the
same fixative for 15 min and transferred to an 18.0 % sucrose solution in 0.1 M PBS with
0.1 % sodium azide at 4 °C overnight. DRG were sectioned longitudinally at 20 μm and
directly mounted onto slides (Superfrost Plus; VWR International, West Chester, PA) in
three series with every forth section on the same slide. This procedure yielded ~24
sections with each slide containing eight sections. Therefore, multiplying the number
per section by 24 will give an estimated total neuronal number per ganglion.
For the double-label fluorescent immunohistochemistry, free-floating brain
sections were rinsed in 0.1 M PBS (2 x 15 min) followed by a 30 min blocking in 10.0 %
normal goat serum (NGS; Vector Laboratories, Burlingame, CA) and 0.4 % Triton X-100
in 0.1 M PBS. Next, sections were incubated with a mixture of primary rabbit anti-HSV1 antibody (1:2000; DakoCytomation, Carpinteria, CA) and mouse anti-GFP antibody
(1:700; Abcam, Cambridge, MA) for 18 h. Sections were then incubated in the mixture of
the secondary goat anti-rabbit (1:700; Jackson Immunoresearch, West Grove, PA) and
goat anti-mouse Alexa-488 (1:700; Jackson Immunoresearch) antibodies with 2.0 %
NGS and 0.4 % Triton X-100 in 0.1 M PBS for 2 h at room temperature. For
immunohistochemical controls, the primary antibody was either omitted or
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preadsorbed with the immunizing peptide overnight at 4 °C resulting in no
immunoreactive staining. Sections were mounted onto slides (Superfrost Plus) and
coverslipped using ProLong Gold Antifade Reagent (Life Technologies, Grand Island,
NY).
After rehydration, DRG sections were processed for detection of H129 (anti-HSV1 antibody, 1:100 dilution; DakoCytomation) and PRV152 (anti-GFP antibody, 1:500
dilution; Abcam) directly on the slides using the same immunohistochemical protocol as
above.
For DRG c-Fos immunostaining on the slides, sections were rinsed in 0.1 M PBS
(2 x 15 min) followed by 1 h blocking in 5.0 % normal horse serum (NHS; Vector
Laboratories) and 0.3 % Triton X-100 in 0.1 M PBS. Sections were then incubated in the
primary rabbit anti-c-Fos (1:500; sc-52; Santa Cruz Biotech, Santa Cruz, CA) antibody
with 10.0 % NHS and 0.3 % Triton X-100 in 0.1 M PBS overnight. Next, the sections
were incubated in the secondary donkey anti-rabbit Cy3 (1:200; Jackson
Immunoresearch) for 3 h, rinsed with 0.1 M PBS (3 x 15 min) and coverslipped with
ProLong Gold Antifade Reagent (Life Technologies). All steps were performed at room
temperature.
2.3.4 Experiment 3: Electrophysiological recordings of IBAT afferent
nerve activity
Siberian hamsters (n=10) were anesthetized with ketamine/xylazine (100 mg/kg,
10 mg/kg; i.p.), a 2 cm dorsal interscapular incision made, IBAT and connective tissue
resected exposing nerves innervating right IBAT lobe. Single nerves were isolated with a
petroleum jelly barrier, severed, then the decentralized nerve placed on silver (32-
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guage) hook electrodes to measure afferent activity. A petroleum jelly mineral oil
mixture (1:1) was applied to the site completely enveloping the electrode/nerve
connection, and then warm mineral oil was pooled into the recording area to insulate
electrical noise, secure the nerve on the electrode, and reduce drying of tissue. A steady
anesthetic plane was maintained with supplemental ketamine by examining toe pinch
repeatedly on all four paws and testing the eye blink response throughout the recording.
Three stainless steel needles connected with silastic tubing to microsyringes affixed to a
microsyringe infusion pump were inserted into right IBAT along the lateral-coronal
plane spaced 4-5 mm apart at a depth of 4 mm each. In a pilot experiment, we used this
delivery system for intra-IBAT application of Evan’s blue dye as a visual surrogate for
CL316,243 and found that the whole ventral IBAT pad turned blue showing excellent
distribution of fluid across the pad by this method (Garretson, J. T. and Bartness, T. J.,
unpublished observations). Ten minutes of basal electrical activity was measured and
served as baseline. At that point, 15 µl of CL316,243 (0.2 ng/kg) or the saline vehicle was
infused at a rate of 3.0 µl/min and recording continued.
Extracellular signals were amplified 10,000 times with a differential AC amplifier
set to low pass filter 100 Hz and high pass filter 1000 Hz (Model 1700; A-M Systems,
Sequim, WA). The analog signal was visualized using an oscilloscope (2530, BK
Precision, Yorba Linda, CA) to optimize signal-to-noise ratio and concurrently identified
via an audio analyzer (74-30-1; FHC, Bowdoin, ME). Data were digitized through
Digidata 1440a data acquisition system (1440a; Molecular Devices, Sunnyvale, CA),
recorded with accompanying Clampex 10.3 software at a 20,000 Hz sampling rate, then
analyzed for number of spikes based on a voltage threshold two standard deviations
above mean non-signal noise via the Clampfit 10.2 data analysis software package. All
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identified waveforms were visually screened whereby any aberrant signals counted by
the software were easily identified and removed from the analyses.
2.3.4.1 Quantitative and statistical analysis
Images were viewed and captured using 100x and 200x magnification with an
Olympus DP73 imaging photomicroscope (Olympus, Tokyo, Japan) with appropriate
filters for Cy3 and Alexa-488. The single-labeled PRV152 and H129, c-Fos and FB
images were evaluated and overlaid with the aid of CellSens (Olympus) and the Adobe
Photoshop CS5 (Adobe Systems, San Jose, CA) software. In every sixth brain section, we
counted cells showing SNS PRV152+SS H129-ir, single cells with PRV152- or H129-ir as
well as c-Fos-ir and FB labeling in every forth DRG section using the manual tag feature
of the Adobe Photoshop CS5 software thus eliminating the likelihood of counting the
same neurons more than once. Absolute neuronal numbers as well as their
corresponding percentages in the brain and DRG were averaged across each examined
region/nucleus/ganglion from all animals. A mouse brain atlas (Paxinos & Franklin,
2007) was used to identify brain areas because no Siberian hamster brain atlas is
available and because of the similarity in size and shape of most of the brain structures
between Siberian hamsters and mice. For the preparation of the photomicrographs, we
used Adobe Photoshop CS5 (Adobe Systems) only to adjust the brightness, contrast and
sharpness, to remove artifactual obstacles (i.e., obscuring bubbles) and to make the
composite plates.
Temperature data were analyzed by one-way repeated measures analysis of
variance (ANOVA) followed by Holm-Sidak’s or Bonferroni’s least significant difference
(PLSD) post-hoc tests using NCSS (version 2007, Kaysville, UT). For
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electrophysiological analysis, spike number across time was quantified by collapsing the
spikes into 10 min bins from the onset of infusion up to 20 min post infusion. The
percent change of mean nerve activity from baseline was compared using a 2 x 2
analysis ANOVA (time x drug), and post hoc analysis of drug effects at individual time
points using Student’s t-test with Bonferroni’s correction. Significance was set at
P<0.05. For simplicity and clarity, exact test results and exact P values are not
presented.
2.4 Results
Following viral infections, hamsters remained asymptomatic until Day 5 after
PRV152 and Day 4 after H129 inoculation, whereupon many began to display some
symptoms of infection including occasional slight loss of body weight and decreased
mobility, but most often an ungroomed coat. All hamsters were euthanized the next day
for histological analyses when such symptoms became apparent. Five out of 8 animals
were equally infected by both PRV152 and H129 viral tracers throughout the neuroaxis
from the hindbrain to the forebrain and therefore were included in the analyses. Three
other animals exhibited over-infection of the CNS either by PRV152 and/or H129
indicated by widespread ‘cloudy plaques’ around the over-infected neurons and were
excluded from the analysis. We noticed both PRV152- and H129-labeled (-infected)
neurons in the IML of the spinal cord (data not shown) with the latter SS innervation of
the IML in accordance with studies showing SS presence in the IML of
amphibians(Horn & Stofer, 1989), prenatal laboratory mice(Funakoshi et al., 2003),
laboratory rats (Yamamoto, Senba, Matsunaga, & Tohyama, 1989) and Djungarian
(Siberian) hamsters (Reuss, 1993).
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2.4.1 Experiment 1: Viral infections in the brain
The dual injections of the SNS nerve tract tracer PRV152 and the SS nerve tract
tracer H129 unilaterally into the same (left) IBAT pad appeared bilaterally in the brain
with slightly ipsilateral domination to the side of inoculation for both viruses.
Both single- and double-labeled neurons were notably present in the hindbrain.
Some of the hindbrain areas with the highest percentages of double-labeled PRV152and H129-ir cells included the lateral paragigantocellular nucleus (LPGi; 13.0 ± 1.2 %;
Table 1), raphe obscurus nucleus (ROb; 12.9 ± 1.4 %; Table 1 and Fig. 2A, B), medial
parabrachial nucleus (MPB; 12.7 ± 1.1 %; Table 1), raphe pallidus nucleus (RPa; 12.6 ±
1.1 %; Table 1 and Fig. 2A) and superior vestibular nucleus (SuVe; 12.1 ± 1.8 %; Table 1).
The RPa and ROb also were among the regions with the highest absolute numbers of
infected neurons (Table 1 and Figs. 2A, B; 3A). Overall, the percentage of double-labeled
hindbrain neurons was ~10.0 % (Fig. 3B).
The midbrain areas with the highest percentages of double-labeled PRV152- and
H129-ir cells were the lateral periaqueductal gray (LPAG; 11.5 ± 2.1 %; Table 1) and
ventrolateral periaqueductal gray (VLPAG; 10.3 ± 1.8 %; Table 1). Among the brain sites
with a predominantly SNS efferent output to IBAT, as compared with a SS afferent input
from the same IBAT pad, were the LPAG (F(1,9)=7.76; P<0.05; Table 1 and Fig. 1C, D),
dorsolateral periaqueductal gray (DLPAG; F(1,9)=42.91; P<0.05; Table 1 and Fig. 2C) and
dorsal raphe nucleus (DR; F(1,9)=5.35; P<0.05; Table 1 and Fig. 2C). As in the hindbrain,
the overall percentage of midbrain double-labeled neurons was ~10.0 % (Fig. 3B).
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Figure 2. Representative viral tract tracing images of BAT SS-SNS feedback loops.
(A) Low and
high
magnification
of the microphotographs
illustrating
PRV152 (green),
H129
(red)
In(B)
the
posterior
hypothalamus
and thalamus
ofsingle
the forebrain,
thesingle
areas
with
and double PRV152+H129 (arrows) immunolabeling in the RPa and ROb following viral injections into IBAT. Gi,
gigantocellular reticular nucleus; LPGi, lateral paragigantocellular nucleus; py, pyramidal tract. n=5. (C) Low and
(D) high magnification of the microphotographs illustrating single PRV152 (green), single H129 (red) and double
PRV152+H129 (arrows) immunolabeling in the PAG following viral injections into IBAT. 3N, oculomotor nucleus;
Aq, aqueduct; DLPAG, dorsolateral periaqueductal gray; DpMe, deep mesencephalic nucleus; DR, dorsal raphe
nucleus; LPAG, lateral periaqueductal gray; mlf, medial longitudinal fasciculus. (E) Low and (F) high magnification
of the microphotographs illustrating single PRV152 (green), single H129 (red) and double PRV152+H129 (arrows)
immunolabeling in the DM following viral injections into IBAT. 3V, third ventricle; LH, lateral hypothalamus; VMH,
ventromedial hypothalamic nucleus. (G) Low and (H) high magnification of the microphotographs illustrating single
PRV152 (green), single H129 (red) and double PRV152+H129 (arrows) immunolabeling in the LH following viral
injections into IBAT. 3V, third ventricle; TC, tuber cinereum area; VMH, ventromedial hypothalamic nucleus. (I)
Low and (J) high magnification of the microphotographs illustrating single PRV152 (green), single H129 (red) and
double PRV152+H129 (arrows) immunolabeling in the PVH following viral injections into IBAT. AHP, anterior
hypothalamic area, posterior part; opt; optic tract; VMH, ventromedial hypothalamic nucleus. (K) Low and (L) high
magnification of the microphotographs illustrating single PRV152 (green), single H129 (red) and double
PRV152+H129 (arrows) immunolabeling in the MPA following viral injections into IBAT. aca, anterior commissure;
MnPO, median preoptic nucleus; MPO, medial preoptic nucleus. Scale bar=200 µm in (A, C, E, G, I and K) and 50
µm in (B, D, F, H, J and L).

40

extensive percentages of double-infected neurons included the sub zona incerta (SubZI;
13.5 ± 3.9 %; Table 1), posterior hypothalamic nucleus (PH; 11.1 ± 1.5 %; Table 1),
dorsomedial hypothalamic nucleus (DM; 9.8 ± 2.3 %; Table 1 and Fig. 1E, F), lateral
hypothalamic area (LH; 9.3 ± 0.6 %; Table 1 and Fig. 2G, H), paraventricular
hypothalamic nucleus (PVH; 11.2 ± 1.8 %; Table 1 and Fig. 2I, J) and anterior
hypothalamic area (AHA; 9.2 ± 4.3 %; Table 1). The infected neurons were more heavily
represented in the medial parvicellular (PaMP) subnucleus within the PVH (absolute
numbers: 137.8 ± 22.1 for PRV152-ir neurons and 129.8 ± 32.8 for H129-ir neurons;
Table 1). The ventromedial hypothalamic nucleus (VMH) was scarcely represented only
by a few PRV152-ir neurons by comparison with other forebrain regions (Table 1 and
Figs. 2G; 2I) as we have seen previous (Bamshad et al., 1999; Leitner & Bartness, 2009;
Song et al., 2008). The overall percentage of PRV152- and H129-ir posterior
hypothalamus and thalamus double-labeled neurons was ~9.0% (Fig. 3B).
In the anterior hypothalamus of the forebrain, the medial preoptic area (MPA),
medial preoptic nucleus (MPO) and median preoptic nucleus (MnPO) had significantly
higher absolute numbers of PRV152-ir neurons as compared with those infected with
H129 (F(1,9)=60.88; P<0.05 for MPA; F(1,9)=5.67; P<0.05 for MPO and F(1,9)=9.81;
P<0.05 for MnPO; Table 1 and Figs. 2K, L; 3B). The H129 immunostaining was
suggestively decreased compared to PRV152 immunostaining in other forebrain areas
such as the lateral preoptic area (LPO), anteroventral preoptic nucleus (AVPO) and
anteroventral periventricular nucleus (AVPe) (F(1,9)=3.96; P=0.081 for LPO, F(1,9)=4.89;
P=0.058 for AVPO and F(1,9)=5.38; P=0.057 for AVPe; Table 1). The percentage of
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Figure 3. Quantification of viral tract tracing of BAT SS-SNS feedback loops.
(A) Brain areas with highest absolute numbers of PRV152- and H129-ir neurons. Note that the MPA contained
predominantly SNS (PRV152) efferent output to IBAT as compared to a SS (H129) afferent input from the same fat
pad. MPA, medial preoptic area; NTS, nucleus of the solitary tract; PAG, periaqueductal gray; PVH, paraventricular
hypothalamic nucleus; RPa, raphe pallidus nucleus. n=5; *P<0.05 vs. PRV152. (B) Percentile quantification of
PRV152 and H129 double-labeled (-infected) in the hindbrain, midbrain, posterior hypothalamus and thalamus,
and anterior hypothalamus. n=5; *P<0.05 vs. hindbrain, midbrain and posterior hypothalamus and thalamus.

anterior hypothalamus double-labeled neurons (~3.5 %) was significantly lower than
those in the posterior hypothalamus and thalamus, midbrain and hindbrain
(F(3,19)=9.61; P<0.05; Fig. 3B), where there was no statistical difference between the
numbers of PRV152/H129 colocalized neurons (Fig. 3B).
The RPa and NTS of the hindbrain, the PAG of the midbrain, and the PVH of the
forebrain contained the highest absolute numbers of both single- and double-labeled
virally-infected neurons (Fig. 3A). The MPA of the forebrain had the highest absolute
number only for PRV152 single-labeled neurons (F(1,9)=60.88; P<0.05 vs. H129; Fig.
3A).
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2.4.2 Experiment 2: IBAT thermogenesis, DRG c-Fos
immunostaining of FB-labeled neurons after intra-IBAT
CL316,243 administration
One aim of this study was to test whether a highly selective β3-adrenoceptor
agonist, CL316,243, stimulated facultative thermogenesis in IBAT. Compared with
saline vehicle-treated right IBAT, intra-left IBAT CL316,243 injections significantly
increased TIBAT within 10 min and this effect remained significant up to 60 min postinjections (t(21)=11.73; P<0.05; Fig. 4A;). The difference in TIBAT between CL316,243and saline-treated fat pads steadily increased to 0.8 °C by 10 min, then slightly dropped
to 0.56 °C by 20 min and stabilized to 0.53 °C by 60 min (Fig. 4B). Tb did not undergo
significant fluctuations over 60 min; however, it was significantly lower compared with
CL316,243-induced temperature increases (t(21)=26.89; P<0.05; Fig. 4A;).
To define which DRG were activated by BAT SNS stimulation, we pre-labeled
DRG neurons innervating IBAT by injecting a conventional retrograde tracer FB
followed 1 wk later by intra-IBAT injections of β3-adrenoceptor agonist CL316,243 into
the left and saline into the right IBAT pad. c-Fos immunostaining and FB labeling in the
DRG pseudounipolar neurons appeared largely at vertebral C1-T5 levels (Figs. 5A-H).
CL316,243 intra-IBAT injections significantly activated C2-C4 DRG neurons ipsilateral
to the CL316,243 injections compared with the contralateral control side (F(1,17)=4.51;
P<0.05 for C2; F(1,23)=5.63; P<0.05 for C3 and F(1,23)=4.85; P<0.05 for C4; Figs. 5G, H).
The c-Fos baseline level before the CL316,243 injections was approximately 4-fold lower
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Figure 4. BAT and core temperature after intra-BAT β3-agonist injections.
(A) The activation of IBAT thermogenesis produced by selective β3-adrenoceptor agonist CL316,243 microinjections
intra-left IBAT in comparison with core body temperature and TIBAT after saline microinjections intra-right IBAT. (B)
Changes in TIBAT after CL316,243 microinjections intra-left IBAT and saline intra-right IBAT over a 60-min period.
n=12; *P<0.05 vs. saline, #P<0.05 vs. core body temperature.

in aforementioned DRG. C4, C5 and T2 DRG contained the highest absolute numbers of
FB-labeled neurons innervating IBAT compared with the contralateral side (F(1,23)=9.06;
P<0.05 for C4; F(1,23)=9.48; P<0.05 for C5 and F(1,23)=6.36; P<0.05 for T2; Figs. 5G, H).
The numbers of FB-labeled DRG neurons were significantly increased at C1-T2
ipsilateral to the FB injections compared with those of the contralaterally FB-labeled
neurons (F(1,11)=10.21; P<0.05 for C1; F(1,17)=8.30; P<0.05 for C2; F(1,23)=30.98; P<0.05
for C3; F(1,23)=9.06; P<0.05 for C4; F(1,23)=9.48; P<0.05 for C5; F(1,23)=4.91; P<0.05 for
C6; F(1,23)=4.81; P<0.05 for C7; F(1,23)=5.67; P<0.05 for T1 and F(1,23)=6.36; P<0.05 for
T2; Figs. 5G, H). C3-C6 DRG had significantly more c-Fos+FB colocalized neurons as
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compared with corresponding counter-DRG (F(1,23)=11.66; P<0.05 for C3; F(1,23)=12.40;
P<0.05 for C4; F(1,23)=9.76; P<0.05 for C5 and F(1,23)=4.66; P<0.05 for C6; Figs. 5G, H).
2.4.3 Experiment 3: Electrophysiological recordings of IBAT afferent
nerve activity
Three simultaneous infusions of saline vehicle along the lateral-coronal plane of
IBAT resulted in no significant change in the rate of IBAT sensory nerve activity above
baseline levels at 10 min or 20 min post-infusions. By contrast, three simultaneous
intra-IBAT infusions of CL316,243 (0.2 ng/kg; same dose as used for TIBAT measures)
significantly elevated mean IBAT sensory nerve activity within 10 min (t(19)=10.43;
P<0.05), with peak activity at 20 min post-infusions (t(19)=12.03; P<0.05; Fig. 5I) and a
significant interaction between drug and time post-injection (F(2,29)=42.69; P<0.05).
2.5 Discussion
We report here the presence of crosstalk between the SNS and SS neural
innervation of the IBAT evidenced by the co-localization of both PRV152 and H129
neural tract tracers especially predominately in the RPa, NTS, PAG, PVH, and MPA
brain regions. In addition, we demonstrated for the first time that intra-IBAT
CL316,243-triggered β3-adrenoceptor stimulation significantly increased TIBAT and
directly activated IBAT-associated DRG neurons. Lastly, intra-IBAT CL316,243triggered β3-adrenoceptor stimulation also significantly elevated afferent nerve activity.
Collectively, these data provide important insight into the distributed neural system
integrating SNS and SS neural circuits innervating IBAT based on the demonstration of
doubly-infected neurons (i.e., possible SNS-SS neural feedback loop neurons) and that
these IBAT afferents are sensitive to β3-adrenoceptor stimulation/IBAT thermogenesis.
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Figure 5. Activation of spinal afferents innervating BAT.
Representative microphotographs of DRG at C4 vertebral level showing c-Fos immunostaining (A, D), FB labeling (B,
E) and c-Fos+FB colocalization (C, F; arrows) after CL316,243 microinjections intra-left and saline intra-right IBAT.
Distribution of c-Fos-ir and FB-labeled neurons in IBAT innervating DRG at C1-T4 vertebral levels contralateral (G)
and ipsilateral (H) to CL316,243 microinjections. The total number of positively-stained neurons per ganglion can be
estimated by multiplying the number per section by 24. n=12; *P<0.05 vs. saline counter-mate. Scale bar=50 µm. (I)
Mean nerve activity from IBAT afferent fibers before (baseline), at 10 min and at 20 min after CL316,243 or saline
microinjections n=5 per group. CL316,243-evoked increase in IBAT sensory nerve activity. (Below) 10 min sample
traces of IBAT afferent fibers before and after infusion of either CL316,243 (top) or saline (bottom). *P<0.05 vs.
saline.
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We found overlap of SNS-SS IBAT-innervating circuits across the neuroaxis.
Specifically, the highest overlap of dually-infected PRV152+H129 neurons was in the
LPGi (~13%), ROb (~13%), MPB (~13%) and RPa (~13%) in the hindbrain; LPAG
(~12%), VLPAG (~10%) in the midbrain and SubZI (~14%), PVH (~11%), PH (~11%) and
DM (~10%) in the forebrain. All these regions previously were reported to be involved in
the control of BAT thermogenesis [(Richard et al., 2010; Ulhoa et al., 2013); for review
see: (Morrison et al., 2014; Bartness et al., 2010b)]. Note that the number of doublelabeled neurons likely was underestimated because infection of a neuron with one virus
can, in principle, reduce the susceptibility to infection by a second virus [phenomenon
of exclusion (Kim, Enquist, & Card, 1999)]. Due to the unpredictable time interval for
each virus to reach each specific area, the neurons on both ascending and descending
pathways to IBAT may not have necessarily showed dual infections despite the selection
of inoculation/post-inoculation time points that optimized the double-virus technique
by matching viral progression rates through the neural axis as closely as possible [for
review see: (ter Horst, 2000)].
Despite predominantly equal SNS and SS representation in many brain regions,
several brain regions had differing amounts of SNS efferent output/SS afferent input to
and from IBAT. That is, the LPAG, DLPAG and DR in the midbrain had largely SNS
output compared with SS input. The PAG receives afferent fibers not only from the
parabrachial nucleus and RPa (Mantyh, 1982), which are critical for the proper
thermoregulatory IBAT function [(Kobayashi & Osaka, 2003); for review see: (Morrison
et al., 2014)], but also from the spinal cord (Pechura & Liu, 1986). We previously
reported that the PAG sends SNS efferents ultimately to white adipose tissue (WAT) in
Siberian hamsters (Bamshad, Aoki, Adkison, Warren, & Bartness, 1998; Nguyen et al.,
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2014; Song, Jackson, Harris, Richard, & Bartness, 2005) as did others in laboratory rats
(Adler, Hollis, Clarke, Grattan, & Oldfield, 2012). Moreover, we recently found that the
dorsomedial PAG was among several other sites with predominantly SNS efferent
output to the inguinal WAT (IWAT) as compared with SS input from IWAT (Ryu &
Bartness, 2014) suggesting differential SNS nodes to different fat pads within the PAG.
Regarding the DR, a profound IBAT thermogenic response is triggered with DR
electrical stimulation (Dib, Rompre, Amir, & Shizgal, 1994); thus, it is not surprising to

Figure 6. Diagram of BAT SS-SNS feedback loops.
A diaphragmatic representation of the efferent sympathetic (green arrows) and afferent sensory (red arrows) brainIBAT neural feedback circuit for control of IBAT functions. BAT, brown adipose tissue; C4-T2, cervical and thoracic
vertebral level; DH, dorsal horn; DRG, dorsal root ganglia; IML, intermediolateral cell column; MPA, medial preoptic
area; NTS, nucleus of the solitary tract; PAG, periaqueductal gray; PVH, paraventricular hypothalamic nucleus; RPa,
raphe pallidus nucleus; SG, sympathetic ganglia.
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see the DR as a component of the SNS outflow to IBAT with our viral neurocircuit
labeling method.
We found the MPA, MPO and MnPO were mostly involved with the SNS outflow
to, but not the SS inflow from, IBAT and these sites are involved in the IBAT
thermoregulatory SNS responses to skin cooling (Nakamura & Morrison, 2008a). This
greater SNS outflow from the MPA than SS inflow supports our previous finding of
relatively sparse MPA H129-infected neurons from IBAT compared with many other
areas (Vaughan & Bartness, 2012), but impressive PRV152-infected neurons (Bamshad
et al., 1999; Leitner & Bartness, 2009; Song et al., 2008). Despite the relatively small
number of MPA-MPO-MnPO SS circuit neurons, this by no means necessarily lessens
its contribution to thermoregulatory signaling from the skin (Nakamura & Morrison,
2008a, 2008b) as the MPA-SS innervation in the present study mainly reflects the SS
pathway originating from the IBAT. IBAT increases thermogenesis in response to cold
exposure in decerebrate rats. However, where most of the midbrain and all of the
forebrain are surgically separated from the hindbrain/peripheral nervous systems
(Nautiyal et al., 2008), the necessity of SS input to the MPA or other rostral brain sites
combined with the presence of PRV152+H129 dually-infected neurons in the hindbrain
indicates that, unlike some of the models proposed for the BAT SNS thermoregulatory
control with the MPA as the ‘origin’ of the descending signals and recipient of the
ascending afferent information [e.g., (Morrison, Madden, & Tupone, 2012)], SS input
may crosstalk with central SNS outflow across the neuroaxis including the hindbrain
(Nautiyal et al., 2008). Indeed, this notion is supported by thermal sensory inputs to the
midbrain and caudal hindbrain implicated in the thermal response to skin cooling and
thermal control in general [e.g., (Uno et al., 2003)].
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Table 1. Distribution of sympathetic (PRV152) and sensory (H129) neurons across the neuraxis
PRV152

H129

PRV152+H129

Percentage of
PRV152+H129

Hindbrain
7N

67.4±12.1

57.6±19.5

11.8±3.0

10.4±1.3

10N

16.0±8.2

14.5±1.2

2.0±1.6

5.7±4.7

12N

24.3±5.2

17.0±8.0

0.7±0.3

1.9±1.0

PnO

38.0±16.0

27.4±9.6

6.4±2.5

11.3±1.1

PnC

51.4±15.1

42.6±8.1

9.2±2.5

10.6±1.9

SuVe

74.2±20.8

59.6±16.1

13.2±2.4

12.1±1.8

MPB

36.6±10.3

40.5±8.4

7.6±1.5

12.7±1.1

LPBI

6.3±2.9

5.3±1.6

1.7±0.8

7.3±4.7

LPBC

23.6±7.1

13.4±5.3

3.0±1.2

9.5±4.3

MPBE

11.3±5.6

11.3±4.7

2.0±0.7

8.0±2.6

LC

29.8±9.9

28.3±5.7

5.0±1.5

8.5±2.4

Bar

16.3±6.6

9.7±4.6

3.8±1.2

11.6±4.8

Pr5

29.0±13.3

26.8±9.6

5.5±2.3

11.3±0.8

LDTg

13.3±4.6

4.3±0.7

1.7±0.7

12.3±7.0

Mo5

18.7±3.3

20.7±1.1

3.7±0.5

10.2±1.0

RMg

83.8±25.9

87.2±17.7

17.2±4.1

11.4±1.2

RPa

159.2±34.0

148.8±41.6

36.2±9.2

12.6±1.1

ROb

154.5±55.9

116.0±14.1

30.5±5.0

12.9±1.4

Gi

52.8±28.8

39.0±13.5

6.2±3.0

6.4±2.2

LPGi

31.0±6.6

29.0±6.8

7.0±1.3

13.0±1.2

DPGi

42.0±17.3

42.3±16.5

7.3±2.8

8.5±1.0

GiV

108.0±19.7

127.2±32.4

19.0±3.0

9.2±1.0

PCRt

14.0±4.1

10.7±3.9

1.3±0.5

4.6±2.0

IO

152.7±41.6

129.3±15.0

25.7±6.1

9.8±1.8

LRt

120.7±36.1

96.0±24.0

18.7±2.9

9.4±1.0

MdV

59.3±39.9

43.0±18.0

9.0±5.9

6.8±3.4

NTS

275.7±60.4

201.2±58.9

33.4±4.2

7.3±1.4

SolC

28.3±5.2

21.0±4.7

5.2±1.1

10.5±2.1

SolCe

7.2±2.8

5.3±2.0

1.3±0.4

9.3±2.6

SolDL

31.8±15.2

27.9±14.8

4.7±1.9

7.7±1.7

SolG

21.7±10.9

15.3±4.5

2.8±0.4

7.1±2.3

SolI

7.4±3.0

4.8±1.5

1.2±0.2

9.3±3.1

SolIM

25.3±8.8

19.5±4.1

3.7±1.3

7.9±2.2

SolM

97.3±12.0

66.0±14.5

12.7±4.3

7.2±2.0

SolV

11.7±3.4

10.8±3.5

2.0±0.2

8.6±1.3

SolVL

45.8±18.3

32.1±10.2

6.0±2.8

7.5±2.4

Pr

25.5±11.2

15.0±6.6

3.8±2.8

6.2±3.1

Midbrain
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PAG

260.6±51.3

109.2±28.8

32.0±5.8

9.6±1.5

DMPAG

32.4±9.3

12.2±4.7

2.8±1.11

6.3±1.2

DLPAG

26.0±6.1

8.4±2.6*

1.8±0.7

5.1±1.6

LPAG

60.0±11.5

30.0±6.9*

8.8±1.3

11.5±2.1

VLPAG

54.8±11.6

18.2±6.0

6.4±1.4

10.3±1.8

DR

23.6±6.7

7.0±2.2*

2.4±0.6

7.7±2.4

DpMe

54.3±20.3

19.0±6.4

6.0±1.9

8.5±3.1

R

18.0±5.5

9.6±2.9

2.6±0.2

9.4±3.3

VTA

32.5±12.7

13.5±4.6

3.5±1.2

7.6±2.8

MPA

79.8±8.9

6.4±3.0*

2.2±1.0

3.0±1.7

MPO

36.4±13.8

6.8±2.6*

1.4±0.9

5.0±3.0

MnPO

17.4±5.2

0.8±0.8*

0.2±0.2

2.0±2.0

LPO

23.8±10.5

1.5±0.8

0.8±0.4

1.7±1.0

AVPO

32.6±9.5

7.8±5.9

1.4±1.0

2.8±1.7

AVPe

23.5±7.9

3.3±1.8

1.3±0.8

3.3±2.3

SCh

13.5±6.9

4.5±1.7

0.5±0.4

1.2±1.0

AHA

7.4±2.2

3.8±2.2

1±0.4

9.2±4.3

AHP

22.8±9.1

9.8±5.5*

2.4±1.3

5.8±2.4

PVH

277.4±55.5

237.8±58.7

48.8±8.7

11.2±1.8

PaAP

15.0±4.9

14.8±7.2

3.5±1.7

10.7±3.2

PaDC

30.6±7.3

36.4±11.3

6.2±1.7

8.9±3.1

PaMP

137.8±22.1

129.8±32.8

23.6±4.2

10.4±1.7

PaMM

12.2±4.9

7.2±2.3

1.8±1.1

6.8±4.5

PaLM

36.0±6.8

35.3±10.7

5.8±1.7

8.5±1.4

PaV

16.7±2.5

16.3±4.2

3.3±1.4

12.6±5.8

PaPo

22.7±12.0

25.4±12.5

7.6±5.2

8.4±2.3

Arc

19.6±7.1

8.2±2.1

2.0±0.9

5.9±2.6

LH

101.6±20.8

40.0±3.9

11.8±1.7

9.3±0.6

VMH

6.4±4.1

0

0

0

DM

83.3±31.8

30.3±5.8

8.7±1.7

9.8±2.3

PH

39.8±12.9

15.8±1.5

5.0±1.1

11.1±1.5

ZI

18±11.0

8.6±4.5

1.2±0.8

2.6±1.7

SubZI

31.6±4.6

22.4±8.9

6.8±2.0

13.5±3.9

Forebrain

Data are expressed as mean number of neurons per brain region ± SEM (n=5), *p<0.05 vs. PRV152. 7N, facial
nucleus; 10N, dorsal motor nucleus of the vagus nerve; 12N, hypoglossal nucleus; AHA, anterior hypothalamic area,
anterior part; AHP, anterior hypothalamic area, posterior part; Arc, arcuate nucleus; AVPe, anteroventral
periventricular nucleus; AVPO, anteroventral preoptic nucleus; Bar, Barrington's nucleus; DLPAG, dorsolateral
periaqueductal gray; DM, dorsomedial hypothalamic nucleus; DMPAG, dorsomedial periaqueductal gray; DPGi,
dorsal paragigantocellular nucleus; DpMe, deep mesencephalic nucleus; DR, dorsal raphe nucleus; Gi, gigantocellular
reticular nucleus; GiV, gigantocellular reticular nucleus, ventral part; IO, inferior olive; LC, locus coeruleus; LDTg,
laterodorsal tegmental nucleus; LH, lateral hypothalamic area; LPAG; lateral periaqueductal gray; LPBC, lateral
parabrachial nucleus, central part; LPGi, lateral paragigantocellular nucleus; LPO, lateral preoptic area; LPBI, lateral
parabrachial nucleus, internal part; LRt, lateral reticular nucleus; MdV, medullary reticular nucleus, ventral part;
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MnPO, median preoptic nucleus; Mo5, motor trigeminal nucleus; MPA, medial preoptic area; MPB, medial
parabrachial nucleus; MPBE, medial parabrachial nucleus external part; MPO, medial preoptic nucleus; NTS, nucleus
of the solitary tract; PaAP, paraventricular hypothalamic nucleus, anterior parvicellular part; PaDC, paraventricular
hypothalamic nucleus, dorsal cap; PAG, periaqueductal gray; PaLM, paraventricular hypothalamic nucleus, lateral
magnocellular part; PaMM, paraventricular hypothalamic nucleus, medial magnocellular part; PaMP, paraventricular
hypothalamic nucleus, medial parvicellular part; PaPo, paraventricular hypothalamic nucleus, posterior part; PaV,
paraventricular hypothalamic nucleus, ventral part; PCRt, parvicellular reticular nucleus; PH, posterior hypothalamic
area; PnC, pontine reticular nucleus, caudal part; PnO, pontine reticular nucleus, oral part; Pr, prepositus nucleus;
Pr5, principal sensory trigeminal nucleus; PVH, paraventricular hypothalamic nucleus; R; red nucleus; RMg, raphe
magnus nucleus; ROb, raphe obscurus nucleus; RPa, raphe pallidus nucleus; SCh, suprachiasmatic nucleus; SolC,
nucleus of the solitary tract, commissural part; SolM, nucleus of the solitary tract, medial part; SolVL, nucleus of the
solitary tract, ventrolateral part; SubZI, sub zona incerta; SuVe, superior vestibular nucleus; VLPAG, ventrolateral
periaqueductal gray; VMH, ventromedial hypothalamic nucleus

The highest percentage of double-labeled neurons reached ~13.0 % in several
hindbrain, midbrain and hypothalamic regions. Compared with more than half of
double-labeled SNS-SS feedback neurons in many of the same and other brain areas
following injections of PRV152 and H129 into the IWAT (Ryu & Bartness, 2014), this
lower rate of double-labeled neurons could reflect a lesser feedback from BAT versus
WAT and/or may reflect a lesser number of BAT functions requiring neural feedback
compared to WAT. That is, the SNS and SS innervations of BAT may primarily reflect its
function in thermogenesis, whereas a neural feedback for its role in lipid and glucose
clearance has not been, to our knowledge, tested and may not require neural feedback
[for review see: (Cannon & Nedergaard, 2004b)]. By contrast, WAT stores/releases lipid
and adipokines and has afferents sensitive to both increases in SNS drive (Bartness,
Shrestha, Vaughan, Schwartz, & Song, 2010) and to leptin (Murphy et al., 2013), that
latter perhaps conveying the amounts of stored lipid via this neural conduit (Bartness,
Liu, Shrestha, & Ryu, 2014b).
We previously demonstrated that an intact SS innervation of BAT is necessary for
normal acute cold exposure-induced IBAT thermogenic increases (Vaughan & Bartness,
2012). To our knowledge, no biochemical signal from BAT responsible for the activation
of local SS nerve terminals has been identified at this time. In this regard, we previously
reported (Song et al., 2009) that the firing frequency of decentralized SS nerve fibers
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innervating IWAT was markedly increased when anesthetized hamsters were injected
with the glucoprivic agent 2-deoxy-D-glucose known to drive SNS outflow and lipolysis
(Brito et al., 2008). Those findings suggest that factors associated with activation of β3adrenoceptors, such as fatty acids and glycerol, might activate BAT afferents. The
necessity of lipolysis for the full effect of SNS/NE-induced BAT thermogenesis is
demonstrated in brown adipocytes harvested from mice where ablation of all protein
kinase A phosphorylation sites on the adipocyte intracellular protein perilipin A result
in an abolished NE-induced lipolytic response and these mice exhibit a severely blunted
(~70%) decrease in NE-induced thermogenesis in vivo (Souza et al., 2007). Other
plausible functions for BAT SNS-SS feedback loops include IBAT afferents directly
sensing changes in TIBAT due to increases in SNS drive and/or to SNS-mediated marked
increases in IBAT blood flow seen in cold-exposed Siberian hamsters, and laboratory
rats and mice [~15-100 fold or more; (Baron et al., 2012; Foster & Frydman, 1978;
Puchalski, Bocker, Heldmaier, & Langefeld, 1987)]. Such a role for SS feedback in the
control of local blood flow has been repeatedly proposed [e.g., (Holzer, 2006; Loesch,
2002)]. Therefore, given that our FB tracing revealed several DRG (C4, C5 and T2) with
the highest numbers of projections to IBAT, this may suggest contribution of more than
one population of SS nerve bundles with heterogeneous capacity to sense the changes in
local temperature, as observed in other organs (Borzan, LaGraize, Hawkins, & Peng,
2005), in blood flow and/or lipolysis-related factors.
In order to further understand both the functional and neuroanatomical basis
underlying SNS-SS interaction relative to IBAT thermogenesis, we injected CL316,243, a
highly selective and potent β3-adrenoceptor intra-IBAT to determine the vertebral levels
at which DRG sensory neurons innervating IBAT are activated by β3-adrenoceptor

53

stimulation. Our goal was to approximate the naturally-occurring stimulation of these
receptors by the SNS release of NE parenchymally, but do so specifically to β3adrenoceptors using CL316,243. CL316,243 significantly increased TIBAT within 10 min
after injection, activated C2-C4 DRG as evidenced by significantly increased c-Fos
immunolabeling in DRG neurons pre-labeled with FB ipsilateral to the injection
compared with the contralateral control side. Functionally, CL316,243 intra-IBAT
injections significantly increased TIBAT and afferent nerve activity within the same 20
min time frame.
Collectively, our results show persuasive evidence of the BAT SNS-SS neural
feedback loops with a coordinated or multiple redundant controls of thermoregulatory
functions. In addition, we demonstrated that sympathetic stimulation directly activates
BAT-associated DRG, and hence sensation, perhaps in relation to its thermogenic
and/or lipolytic response. Finally, the approach of direct, intra-IBAT injection combined
with c-Fos-ir in DRGs and/or electrophysiologic assessment of BAT afferent activity
provides a model system with which to determine BAT sensory nerve activators
analogous to our study of WAT afferents using the same methodologies (Murphy et al.,
2013).
2.6 Author contributions
T.J.B, V.R., Y.L., and C.V. designed the neuroanatomical tracing experiments.
V.R. performed the tracing, the BAT temperature recording, and DRG immunostaining
experiments. T.J.B. and J.G. designed and J.G. performed the neurophysiological BAT
afferent recording experiments.
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3.1 Abstract
Objective: Metabolic challenges, such as a cold environment, stimulate
sympathetic neural efferent activity to white adipose tissue (WAT) to drive lipolysis,
thereby increasing the availability of free fatty acids as one source of fuel for brown
adipose tissue (BAT) thermogenesis. WAT is also innervated by sensory nerve fibers that
network to metabolic brain areas; moreover, activation of these afferents is reported to
increase sympathetic nervous system outflow. However, the endogenous stimuli
sufficient to drive WAT afferents during metabolic challenges as well as their functional
relation to BAT thermogenesis remain unknown. Method: We tested if local WAT
lipolysis directly activates WAT afferent nerves, and then assessed whether this WAT
sensory signal affected BAT thermogenesis in Siberian hamsters (Phodopus sungorus).
Results: 2-deoxyglucose, a sympathetic nervous system stimulant, caused β-
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adrenergic receptor dependent increases in inguinal WAT (IWAT) afferent
neurophysiological activity. In addition, direct IWAT injections of the β3-AR agonist
CL316,243 dose-dependently increased: 1) phosphorylation of IWAT hormone sensitive
lipase, an indicator of SNS-stimulated lipolysis, 2) expression of the neuronal activation
marker c-Fos in dorsal root ganglion neurons receiving sensory input from IWAT, and
3) IWAT afferent neurophysiological activity, an increase blocked by antilipolytic agent
3’5-dimethylpyrazole. Finally, we demonstrated that IWAT afferent activation by
lipolysis triggers interscapular BAT thermogenesis through a neural link between these
two tissues. Conclusions: These data suggest IWAT lipolysis activates local IWAT
afferents triggering a neural circuit from WAT to BAT that acutely induces BAT
thermogenesis.
3.2 Introduction
Adipose tissue is connected to the CNS via afferent and efferent nerve fibers
directly innervating each fat depot. While adipose efferents are entirely
catecholaminergic (Youngstrom & Bartness, 1995), adipose afferents are primarily
unmyelinated c-fibers—positive for substance p and calcitonin gene-related peptide
(CGRP)—and receptive to a variety of stimuli (Giordano et al., 1996). Although the
anatomical reality of WAT afferents was initially discovered by Fishman and Dark
(Fishman & Dark, 1987), the first functional role of neural afferents arising from white
adipose tissue (WAT) was demonstrated by Niijima (Niijima, 1998) by injecting the
adiposity hormone leptin directly into WAT then measuring neurophysiological activity
in decentralized (sensory) nerve fibers connected to the tissue. These results have been
interpreted to suggest that local leptin, secreted by WAT in proportion to adipocyte size
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and number, is transduced as a neural signal proportional to the amount of stored
energy (Caro, Sinha, Kolaczynski, Zhang, & Considine, 1996). However, WAT afferents
also increase their neurophysiological activity in response to adenosine and
bradykinin—indicating an active role of these afferents in blood pressure sensation (Shi
et al., 2012). Despite the variety of signals sensed by WAT afferents, each
neurophysiologically effective stimulus similarly increases sympathetic nervous system
(SNS) drive to WAT and other tissues in a positive feedback WAT-brain-SNS reflex
circuit termed the “adipose afferent reflex” (AAR) (Niijima, 1999; Shi et al., 2012).
Indeed, our viral tracing studies expose the neuroanatomical framework for this AAR
wherein WAT afferents are networked to WAT efferents throughout metabolically
relevant CNS nuclei (e.g. intermediolateral nucleus of the spinal cord, nucleus of the
solitary tract, periaqueductal gray, dorsomedial, lateral, arcuate and paraventricular
hypothalamus). (Bartness & Song, 2007b). In addition, these studies reveal a high
degree of neuroanatomical overlap between neuronal populations at multiple peripheral
and central levels of the neuraxis including WAT sensory and brown adipose tissue
(BAT) SNS innervation (Song et al., 2009; Vaughan et al., 2011). Thus, functional and
neuroanatomical sensory-motor links between WAT and the SNS have been established
(Murphy et al., 2013; Ryu & Bartness, 2014); however, the sensitivity of WAT afferents
to local lipolytic activity of the tissue and the potential for these afferents to induce heat
production in BAT have not been fully investigated.
Among all functions of WAT, its catabolism and subsequent efflux of stored
energy is a rapid and necessary process for the release of fuels when energy demand is
high with an evolutionarily highly conserved mechanism across species including nonmammals (Bartness et al., 2014a; Migliorini et al., 1992). During an energetic challenge
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such as cold exposure, norepinephrine released by axon terminals of post ganglionic
SNS neurons binds β3-adrenorecptors (β3-AR)—present on adipocytes (Lafontan et al.,
1997)—initiating a lipolytic cascade that is dependent on the phosphorylation of
hormone sensitive lipase (HSL) and leads to the preferential release of long-chain freefatty acids (FFAs) and glycerol as useable energy (Bartness & Song, 2007a; Belfrage et
al., 1981). Peripheral injection of 2-deoxyglucose (2DG), a glucoprivic and thus
sympathomimetic drug, causes SNS dependent mobilization of triglycerides from WAT
and also increases WAT afferent activity within minutes (Song et al., 2009). This efflux
of substrates from WAT occurs locally first, then is circulated throughout the body/brain
and oxidized as fuel when glucose is not readily available/sufficient for energy demand
(Lass, Zimmermann, Oberer, & Zechner, 2011) or converted to heat via uncoupled
oxidative phosphorylation by BAT, a tissue similarly dependent on SNS innervation to
trigger thermogenesis. Thus, we hypothesize that WAT afferents activated by
glucoprivation may be sensing locally released lipolytic products thereby transducing
lipolysis into rapid neural signals communicated to the CNS (Song et al., 2009). If this is
true, then lipolysis sensation by WAT afferents likely induces BAT thermogenesis
because 1) lipolysis provides substrates that are required for BAT thermogenesis
(Haemmerle et al., 2006; Labbé et al., 2015) and 2) the strikingly similar patterns of
WAT afferent and BAT efferent neural connectivity (Song et al., 2009; Vaughan et al.,
2011). To investigate these hypotheses, we first tested if WAT lipolysis and/or its
products were sufficient to drive spinal afferent nerves receiving sensory input from
subcutaneous inguinal WAT (IWAT), then we tested whether stimulation of lipolysis
sensing IWAT afferents triggers interscapular BAT (IBAT) thermogenesis.
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3.3 Methods and Materials
3.3.1 Animals
Adult male Siberian hamsters (Phodopus sungorus; ~3-4 months old) from our
breeding colony were individually housed in a long day photoperiod (16h:8h light:dark
cycle; at 22 ± 2 ºC) with free access to water and rodent chow. Siberian hamsters were
used because of the expanding literature characterizing the anatomy of their neuroadipose axis (Bartness et al., 2014a) and the apparent conservation of adipocyte
catabolism among mammalian species (Migliorini et al., 1992). All procedures were
approved by the Georgia State University Institutional Animal Care and Use Committee
and are in accordance with Public Health Service and United States Department of
Agriculture guidelines.
3.3.2 Neurophysiological recordings of IWAT afferent nerve activity
Siberian hamsters (n=13, unilateral recordings; n=16, bilateral recordings) were
anesthetized with ketamine (100 mg/kg)/xylazine (10 mg/kg, i.p.), then dissected by a 2
cm dorsal ventral incision. IWAT and connective tissue were resected and isolated from
surrounding tissue, after which the nerves innervating right and/or left IWAT were
exposed. Single nerve bundles from these WAT nerves were isolated and severed
proximal to the electrode placement site to disconnect efferent fibers, finally the afferent
ends of decentralized nerves were placed on platinum-iridium (32-gauge) hook
electrodes. A petroleum jelly mineral oil mixture (1:1) was applied to the sites to
completely surround the electrode/nerve connection, then warm mineral oil was pooled
into the recording area to insulate electrical noise, prevent aqueous infusions from
leaking to other tissue, secure the nerve on the electrode, and reduce drying of tissue. A
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steady anesthetic plane was maintained with supplemental ketamine (50 mg/kg, s.c.) by
examining toe pinch and eye blink responses throughout the recordings.
For unilateral recordings, baseline neurophysiological spike activity in IWAT
afferents was recorded for 5 min as reported (Song et al., 2009), then hamsters received
either propranolol (40 mg/kg, i.p.) or sterile saline vehicle (i.p.) and spikes were
recorded for an additional 5 min. Finally, 2DG (500 mg/kg, s.c.) was administered and
IWAT afferent activity was measured for an additional 10 min.
For bilateral recordings, decentralized nerves from left and right IWAT were each
placed on electrodes then three sharp stainless steel needles connected with Silastic
tubing to Hamilton microsyringes (Hamilton Company, Reno, NV) were inserted into
left and right IWAT along the lateral-coronal plane spaced 4-5 mm apart at a depth of
approximately 4-5 mm each (diagram of procedure, Fig. 8a). Ten minutes of basal
electrical activity was measured followed by 15 µl of the β3 adrenergic receptor agonist
CL316,243 (CL, 0.2 ng/kg or 0.1 ng/kg) and saline vehicle was infused simultaneously
into the opposite IWAT pad at a rate of 3.0 µl/min for 5 min. CL stimulation is
commonly used to simulate SNS activity to adipose tissue and reliably induces lipolysis
in vivo and in vitro (Atgie, Faintrenie, Carpene, Bukowiecki, & Geloen, 1998b;
Umekawa, Yoshida, Sakane, & Kondo, 1997). A separate cohort of animals was
pretreated with the antilipolytic drug 3’5-dimethylpyrazole (DMP, 12 mg/kg, i.p.)
(Gerritsen & Dulin, 1965; Locci-Cubeddu & Bergamini, 1983; Masiello et al., 2002) 20
min before IWAT infusions of CL (0.2 ng/kg) and saline. Eicosopentanoic acid (EPA)
and arachidonic acid (AA) are both highly mobilized from adipose tissue during
stimulated-lipolysis at ratios to other mobilized FAs seemingly conserved across
species(Conner, Lin, & Colvis, 1996; Raclot & Groscolas, 1993). Thus, EPA and AA were
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used as representative FAs—of potentially many more FA species—that may signal acute
and local lipolysis to WAT afferents. Doses for EPA[2.94 µM in 15 µl Tocrisolve, ~8.91
mg/kg] and AA[0.27 µM in 15 µl Tocrisolve, ~0.81 mg/kg] were calculated from studies
that measured net output of lipolytic products from adipose fragments in rats (Raclot &
Groscolas, 1993; Raclot et al., 1995); accordingly, physiologically relevant levels of EPA
and AA were injected into WAT to assess whether lipolytic products stimulate WAT
afferents directly. Infusions of drug or vehicle were counterbalanced by side to control
for possible side bias of IWAT afferent innervations.
Extracellular signals were amplified 10000 times with a differential AC amplifier
set to low pass filter 100 Hz and high pass filter 1000 Hz (Model 1700; A-M Systems,
Sequim, WA). Analog signals were visualized on an oscilloscope (Model 2530, BK
Precision, Yorba Linda, CA), audio analyzer (Model 74-30-1; FHC, Bowdoin, ME), and
digitized through a Digidata data acquisition system (Model 1440a; Molecular Devices,
Sunnyvale, CA) at a 20,000 Hz sampling rate. Recordings were captured with
accompanying Clampex 10.3 software and analyzed for the number of spikes based on a
voltage threshold two standard deviations above mean non-signal noise via Clampfit
10.3 data analysis software package. All counted waveforms were visually screened, and
non-physiological noise detected with the set threshold was easily identified and
removed from analysis. Percentage change from baseline nerve activity was calculated
for 10 min bins for each nerve recording session, then the difference between IWAT
afferent activities from CL injected pads and saline injected pads was calculated and
used for statistical analysis.
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3.3.3 Western blot analysis of lipolysis induced by CL
Using an identical infusion protocol to bilateral electrophysiology experiments,
but without IWAT afferent dissection/dissociation from the CNS, CL (0.1 ng/kg or 0.2
ng/kg) was infused into one IWAT pad simultaneously, while saline vehicle was infused
into the contralateral IWAT pad. Animals receiving a high dose of CL (0.2 ng/kg) were
pretreated with either DMP (20 min prior, 12 mg/kg, i.p.) or saline vehicle, and animals
receiving a lower dose of CL (0.1 ng/kg) received no pretreatment. Fifteen minutes after
the start of bilateral infusions (15 µl each pad, 3 loci, 3.0 µl/min for 5 min), ~100 mg of
each IWAT pad was quickly removed, snap frozen in liquid nitrogen to preserve protein,
then stored at -80 oC until analysis by Western blot.
Frozen adipose tissue samples were homogenized using microcentrifuge tubes
containing 0.5 mm zirconium oxide beads homogenization buffer containing 50 mM
HEPES, 100 mM NaCl, 10 % SDS, 2 mM EDTA, 0.5 mM DTT, 1 mM benzamidine,
protease inhibitor cocktail (Calbiochem, EMD Chemicals, Gibbstown, NJ), and
phosphatase inhibitor cocktail (Thermo Fischer Scientific, Rockford, IL) at a ratio of 1:2
tissue weight (mg): homogenization buffer (μl). The samples were agitated 2 X 1 min
using a bullet blender tissue homogenizer and then centrifuged at 13,000 g for 10 min at
4 °C. The infranatant was collected, aliquoted and stored at -80 °C until protein content
was determined. Samples were diluted 1:10 in dH2O and the protein content of the
tissue extract was determined using the bicinchoninic acid protein assay kit (Thermo
Fisher Scientific, Rockford, IL). Samples containing 10 μg of protein were mixed with
loading buffer and heated at 95 °C for 5 min, electrophoresed on a low-bis SDSPAGE[10 %: 0.08 % acrylamide:bis] and transferred to polyvinylidene difluoride
membranes. Membranes were cut in half so that immunoblotting could be done on
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duplicate lanes with different antibodies from the same gel. Cut membranes were
incubated in Tris buffered-saline (TBS) with 4 % nonfat dry milk and 0.3 % Tween
blocking solution for 2 h, then incubated in primary antibody at 4 °C (anti-ATGL, antiHSL, anti-phospho-HSL, anti-beta-actin, 1:1000; Cell Signaling Technology, Danvers,
MA) in TBS-4 %milk-0.3 % Tween for 2 days. Immunoblots were rinsed 4 X 5 min in
TBS-Tween (TBST) and then incubated with secondary antibody (Anti-rabbit IgG HRPlinked antibody, 1:1000; Cell Signaling Technology, Danvers, MA) for 2 h at room
temperature. The immunoblots were rinsed 3 X 10 min in TBST and then incubated
with LumiGLO chemiluminescent kit (Cell Signaling Technology, Danvers, MA) to
reveal bands.
3.3.4 Fast Blue (FB) labeling and CL administration
Siberian hamsters (n = 10) were anesthetized with ketamine/xylazine (100
mg/kg, 10 mg/kg; i.p.) and ventral lateral 2 cm incisions were made to expose both
IWAT pads. The neuronal tracer FB (1.0 %; EMS-CHEMIE GmbH, Gross-Umstadt,
Germany) was injected with a microsyringe into eight separate loci (2 µl/locus) of the
left and right IWAT. After the last injection, the incision was closed with sterile wound
clips and ketofen (5 mg/kg, s.c.; Fort Dodge Animal Health, Fort Dodge, IA) was
administered for 3 d postinjection to minimize postoperative discomfort.
One week later, CL (0.2 ng/kg in 0.9 % sterile saline) was injected into one IWAT
pad across eight separate loci with nearly simultaneous intra-contralateral IWAT
injections of the saline vehicle (2 μl/locus for a total of 16 μl) served as a within animal
control. Injections of drug or vehicle were counterbalanced by side to control for
possible side bias of IWAT afferent innervations. The skin was gently pinched closed,
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and sterile saline-soaked gauze was laid over top of the incision site for 60 min until
hamsters were sacrificed and DRGs processed for c-Fos immunohistochemistry.
3.3.5 Tissue fixation and c-Fos immunostaining on DRGs
Hamsters were overdosed with pentobarbital sodium (Sleep Away; 300 mg/kg)
and transcardially perfused with 75 ml of 0.9 % heparinized saline followed by 150 ml
4.0 % paraformaldehyde in 0.1 M PBS, pH 7.4, directly into the aorta. The DRGs (T12L2) were extracted, the epineurium debrided and postfixed in the same fixative for 15
min at 4 °C, then transferred to a 18.0 % sucrose solution in 0.1 M PBS with 0.1 %
sodium azide and stored at 4 °C until they were sectioned at 20 µm on a freezing
microtome. Sections were received directly onto slides (Superfrost Plus, VWR
International) in three series with every fourth section on the same slide. This procedure
yielded ~24 sections with each slide containing eight sections. Thus, an estimated total
neuronal number per ganglion could be obtained by multiplying the number per section
by 24 or averages here by 8.
For DRG c-Fos immunostaining on slides, sections were rinsed in 0.1 M PBS (2 x
15 min) followed by 1 h blocking in 5.0 % normal horse serum (NHS; Vector
Laboratories) and 0.3 % Triton X-100 in 0.1 M PBS. Sections were then incubated in
primary rabbit anti-c-Fos (1:500; sc-52; Santa Cruz Biotechnology) antibody with 10.0
% NHS and 0.3 % Triton X-100 in 0.1 M PBS overnight. Next, the sections were
incubated in secondary donkey anti-rabbit Cy3 (1:200; Jackson ImmunoResearch) for 3
h, rinsed with 0.1 M PBS (3 x 15 min) and coverslipped with ProLong Gold Antifade
Reagent (Life Technologies). All steps were performed at room temperature.
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3.3.6 Brown fat transponder implantation, temperature recordings,
and acute surgical denervation of IWAT
Siberian hamsters (n = 36) were anesthetized with ketamine/xylazine (100
mg/kg, 10 mg/kg, i.p.) and a dorsal 2 cm interscapular incision was made to expose
IBAT. One electronic transponder (Bio Medic Data Systems) with a built-in
temperature sensor was gently implanted under one IBAT pad of each hamster, the
temperature of which was read with a handheld DAS-7007R scanner (Bio Medic Data
Systems) as we have used successfully previously (Brito et al., 2007; Ryu, Garretson,
Liu, Vaughan, & Bartness, 2015a; Song et al., 2008). The incision was closed with sterile
wound clips.
After two weeks of recovery, hamsters were again anesthetized with
ketamine/xylazine (100 mg/kg, 10 mg/kg, i.p.) then a ventral lateral 3 cm incision was
made to expose right IWAT. Nerves innervating the ventral portion of IWAT were either
left intact, or surgically destroyed (Vaughan et al., 2014) to test whether WAT lipolysis
sensed by local afferents could drive BAT thermogenesis (diagram of procedure, Fig.
12a). CL (0.2 ng/kg) or saline vehicle, was injected intra-right ventral IWAT exactly as
above at three loci (5 µl/locus for a total of 15 µl). This dose was chosen based on
neurophysiological recordings demonstrating dose-dependent IWAT afferent activation,
Western blot data confirming increased lipolysis by significant pHSL/HSL increases of
the pad delivered, and previous studies that determined CL microinjections of 0.2 ng/kg
into IBAT did not affect core body temperature (Ryu et al., 2015). The incision was
immediately covered with a warm saline-soaked gauze pad, animals were then moved to
a circulating water warming pad set to 37 ° C and remained there under heat lamp with
ambient air surrounding the animals stable at ~35-36 ° C. Temperature recordings from
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IBAT were started immediately after the animal reached the warming pad then
monitored every 5 min for 1 h postinjection as done previously (Ryu et al., 2015a). Core
body temperature in these anesthetized animals was measured using a rectal
temperature sensor connected to BAT-10 Thermometer (Physitemp Instruments).
3.3.7 Data analysis
3.3.7.1 Neurophysiological recordings
The numbers of WAT afferent action potentials occurring as a function of time
were integrated into either 30 sec bins and compared across treatments for unilateral
recordings, or 10 min bins for bilateral recordings, where the onset of infusion up to 20
min post infusion were compared against the pre-infusion 10 min baseline recordings.
Percent change mean nerve activity from contralateral (vehicle-infused) IWAT was
compared using one-way ANOVA for each treatment from baseline nerve activity. Nerve
activity at individual time points across experiments were compared using Student’s t
tests with Bonferroni correction via SigmaPlot (v12.3; Systat Software Inc., San Jose,
CA). Results were considered significant if mean nerve activity in unilateral recordings—
or percent change from baseline activity in bilateral recordings—differed from vehicle
control, p < 0.05.
3.3.7.2 Western blot protein analysis
Band intensity was quantified based on optical densitometry measurements
using ImageJ (US National Institutes of Health, Bethesda, MA). The values for
HSL/actin, and pHSL/actin were collected and ratios of pHSL/HSL were compared
using paired samples t-tests between ipsilateral and contralateral IWAT within animals
via SigmaPlot (v12.3; Systat Software Inc., San Jose, CA). Data are displayed (Fig. 9) as
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arithmetic change in pHSL/HSL for clarity of presentation. Results were considered
significant if mean pHSL/HSL from CL-infused pads differed from their contralateral
vehicle-infused control, p < 0.05.
3.3.7.3 c-Fos-ir and FB colocalization
All labeled cells from three central sections of each DRG were counted from
captured images by experimenters blind to treatment conditions. Raw totals for each
label (e.g., c-Fos and FB) as well as c-Fos+FB colocalized cells were compared between
drug treatments using multiple Mann-Whitney U tests at each ganglionic level. In
addition, the percentage of FB labeled cells expressing c-Fos was compared between
drug treatments at each ganglionic level and combined across all ganglia to demonstrate
the specificity of CL infusion to individual IWAT afferent neurons. Comparisons were
considered statistically different when DRG labeling ipsilateral to CL infusion differed
from the contralateral vehicle-infused counterpart, p < 0.05.
3.3.7.4 BAT and rectal temperature recordings
Temperature and change in temperature from the “0 min” time point were each
analyzed by repeated measures two-way ANOVA by drug treatment and the state of
IWAT neural connectivity. Preplanned comparisons between treatments at each time
point were conducted using multiple Student’s t test with Bonferroni correction.
Comparisons were considered statistically different when temperature or change in
temperature from baseline differed from animals whose IWAT was injected with saline
and innervating nerves intact, p < 0.05.

68

3.4 Results
2DG significantly increased neurophysiological activity of IWAT afferents in both
0-5 min and 5-10 min post-stimulus time intervals (Student’s t test with Bonferroni
correction; n = 13; baseline, p = 0.143; pretreatment, p = 0.448; 0-5 min, p = 0.050 ; 510 min, p = 0.009, Fig. 7), and the 2DG-induced increase was blocked by pretreatment
with propranolol relative to saline infusions.

Spikes 30/sec
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160

Saline Pretreatment
Propranalol Pretreatment

120

*

80
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40
0
Baseline Pretreatment

0-5min

5-10min

Figure 7. Glucoprivation increases IWAT multiunit nerve spiking in a β-AR dependent fashion.
2DG (500 mg/kg, i.p.) increased IWAT multiunit spiking, an effect blocked by pretreatment with β-AR antagonist
propranolol. Bars represent number of spikes per 30 sec of IWAT afferents in hamsters that received either
propranolol (40 mg/kg, s.c.) or saline vehicle (s.c.) pretreatment prior to 2DG application. * p < 0.05.

IWAT administration of the high dose of CL (0.2 ng/kg, Fig. 8b, c) also
significantly increased neurophysiological spike activity beginning 5-10 min after the CL
infusion, and lasting until the end of the recording session. IWAT neurophysiological
spike activity was not increased in vehicle-injected contralateral IWAT or when CL was
infused at a dose insufficient to induce lipolysis (0.1 ng/kg, Fig. 8b, c, Fig. 9). DMP
blocked the ability of a high dose of CL to stimulate WAT afferents , and interestingly
inhibited their activity from 10-20 min post-infusion (repeated measures ANOVA; CL
0.2 ng/kg, n = 7, p = 0.002; CL 0.1 ng/kg, n = 4, p = 0.964; CL 0.2 ng/kg + 12 mg/kg
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DMP, n = 5, p = 0.158; Student’s t test with Bonferroni correction; CL 0.2 ng/kg, n = 7,
0-10 min, p = 0.022, 10-20 min, p = 0.002; CL 0.1 ng/kg, n = 4, 0-10 min, p = 0.779, 1020 min, p = 0.968; CL 0.2 ng/kg + 12 mg/kg DMP, n = 5, 0-10 min, p = 0.979, 10-20
min, p < 0.001).

Figure 8. Intra-adipose β3-AR agonism increases IWAT multiunit nerve activity.
(a) Diagrammatic representation of real-time in vivo bilateral multiunit electrophysiology of WAT afferent nerves.
Afferent nerves resected from ventrally exposed IWAT (blue curved lines), cut proximal to electrodes (gray hook
pairs) to eliminate efferent interference, and analyzed for multiunit spike frequency over time. Symmetrically placed
infusion needles indicate bilateral simultaneous infusion of lipolytic drug CL316,243 (CL, β3-AR agonist) and its
sterile saline vehicle (no drug) in the contralateral negative control pad. (b) CL dose-dependently increased IWAT
multiunit spiking, an effect blocked by pretreatment with the antilipolytic drug 3,5-dimethylpyrazole (DMP, 12
mg/kg, i.p). Data are expressed as a percentage change of activity from CL-infused pad over contralateral to eliminate
whole animal IWAT nerve variability caused by the recording/injection procedure. Inset is a representative single
spike to display acquired waveforms. (c) Representative (20 sec) traces from IWAT afferents and contralateral
counterparts at baseline and 20 min post-infusion where the ipsilateral IWAT was infused with CL at either 0.2 ng/kg
(top), 0.1 ng/kg (middle), or 0.2 ng/kg 20 min after pretreatment with antilipolytic drug DMP (bottom). Scale bars on
first trace apply to all traces. Dotted line separates ipsilateral vs contralateral IWAT afferent recordings from each of
the three representative animals. * p < 0.05.

CL-induced lipolysis was confirmed by examining the change in ratios between
pHSL and HSL using Western blot as a well-established marker for fat-pad-specific
sympathetically dependent lipolysis (Bartness et al., 2014a; Buettner et al., 2008). CL
infusion (0.2 ng/kg) increased pHSL:HSL after 15 min but did not affect pHSL:HSL
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when animals had been pretreated with DMP (12 mg/kg, CL 0.2 ng/kg) or CL only at a
lower dose (0.1 ng/kg, Fig. 9) (paired t tests; CL 0.2 ng/kg, n = 17, p = 0.015; CL 0.1
ng/kg, n = 5, p = 0.193; CL 0.2 ng/kg + 12 mg/kg DMP, n = 5, p = 0.515). ATGL did not
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pHSL/HSL ratio
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differ among treatment groups (p > 0.05).
Sal CL0.2 CL0.1 CLDMP
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Figure 9. Intra-adipose CL increases pHSL/HSL indicating β3-AR induced lipolysis.
(a-b) Western blot analysis of the ratio of pHSL to HSL and ATGL reveals increased stimulated lipolysis with 0.2
ng/kg but not 0.1 ng/kg CL 15 min after infusion. In addition, pretreatment with DMP (i.p.) blocked CL stimulatory
effects. Colored bars indicate (a) the mean ratio of pHSL to HSL and (b) ATGL in CL-injected IWAT compared with
their saline-injected contralateral control IWAT (white bar). Error bars indicate SEM. Representative blots are
provided as the inset with the label color and order of the bars used to indicate treatment (all units in ng/kg). *
different from contralateral saline injected pad, p < 0.05.

FB neurotracing and c-Fos colocalization revealed a specific activation of DRG
neurons connected directly to IWAT on the side ipsilateral to the high dose of CL
infusion (0.2 ng/kg, Fig. 10a-f, j) despite nearly identical neurotracer labeling (Fig. 10h)
and only a trend toward higher overall c-Fos-ir (Fig. 10i) (Mann-Whitney Rank Sum
Tests; FB, T12, n = 7, p = 0.905; T13, n = 7, p = 0.571; L1, n = 7, p = 0.556; L2, n = 7, p =
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0.486; L3, n = 7, p = 0.286; c-Fos-ir, T12, n = 7, p = 0.556; T13, n = 7, p = 0.250; L1, n =
7, p = 0.111; L2, n = 7, p = 0.686; L3, n = 7, p = 0.905; Colocalized, T12, n = 7, p = 0.190;
T13, n = 7, p = 0.502; L1, n = 7, p = 0.032; L2, n = 7, p = 0.030; L3, n = 7, p = 0.041). In
addition, the percent of FB labeled cells expressing c-Fos tended to increase in L3 but
was significantly higher at ganglionic levels L1, L2, and overall across T12-L3 (MannWhitney Rank Sum Tests, T12, n = 7, p = 0.215; T13, n = 7, p = 0.442; L1, n = 7, p =
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Figure 10. Intra-adipose β3-AR agonism increases c-Fos-ir in DRG neurons connected to IWAT.
(a-f) Representative images of Fast Blue (FB, a, d) positive, c-Fos (b, e)-ir, and colocalized (c, f) neurons in DRG at the
L2 vertebral level from the same animal both contralateral (top) and ipsilateral (bottom) to CL injections. Scale bar =
100 µm. White arrows indicate some but not all labeled cells of interest and rows are separated by treatment. (g-i)
Neuronal number counted from three central-most sections of each DRG, each animal, and both treatments positive
for FB (g), c-Fos-ir (h), or both (i). (j) Percentage of FB labeled neurons expressing c-Fos at each vertebral level (T12L3) from animals injected with CL into their ipsilateral IWAT and saline vehicle into their contralateral IWAT. * p <
0.05, ** p < 0.001.

EPA, AA, and a cocktail of both together each significantly increased
neurophysiological activity of IWAT afferent nerves (Fig. 11a, b) (repeated measures
ANOVA; EPA, n = 6, p = 0.013; AA, n = 3, p = 0.003; EPA+AA cocktail, n = 4, p =
0.005). Post hoc analysis revealed lipolytic products EPA and AA each increased
multiunit activity to a similar magnitude and latency of effect as the high dose of CL.
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Figure 11. Intra-IWAT eicosopentanoic acid (EPA) and arachidonic acid (AA) increases IWAT
multiunit nerve activity.
(a) EPA, AA, and a mixture of EPA + AA all increased IWAT multiunit spiking with a similar magnitude and latency
to effect. Data are expressed as a percentage change of activity from baseline nerve activity. (b) Representative (8 sec)
traces from IWAT afferents and contralateral counterparts at baseline and 20 min post-infusion. Scale bars on first
trace apply to all traces. Dotted line separates ipsilateral vs contralateral IWAT afferent recordings from each of the
three representative animals. * p < 0.05.

(Student’s t test with Bonferroni correction; 0-10 min: EPA, n = 6, p = 0.047; AA, n = 3,
p = 0.019; 10-20 min: EPA, n = 6, p = 0.015; AA, n = 3, p = 0.003).
IBAT temperature change from baseline was significantly increased after CL
infusion in WAT pads with intact neural innervation (repeated measures ANOVA; n =
36, p < 0.001) as early as 5 min post infusion and persisted for every time point
measured (Fig. 12c). This effect was abolished when WAT was denervated before CL
infusion and did not increase when saline was infused into denervated WAT (Fig. 12c).
Anesthetized hamsters experienced mild post anesthesia-induced hypothermia (Shimizu
& Saito, 1991) after which IBAT (repeated measures ANOVA; n = 36, p < 0.001) and
rectal raw temperatures (repeated measures ANOVA; n = 36, p < 0.001) slowly
increased over time throughout the experiment (Fig. 12b, d); however, neither IBAT
(repeated measures ANOVAs; n = 36, p < 0.183) nor rectal (repeated measures ANOVA;
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n = 36, p = 0.922) raw temperatures differed among treatment groups at baseline or any
subsequent time point measured (Fig. 12b, d).

Figure 12. CL-induced IWAT afferent stimulation is sufficient to increase BAT thermogenesis.
(a) Diagrammatic representation of the experimental setup. IWAT was either denervated or nerves left intact then
injected with saline or a dose of CL 316,243 (0.2ng/kg) shown to increase IWAT afferent activity. (b) BAT
temperature, (c) change in BAT temperature from baseline and (d) rectal temperature over the 60 minute recording
period all demonstrate WAT afferent activation specifically increases BAT thermogenesis, * p < 0.05.

3.5 Discussion
IWAT afferents are activated by 2DG-induced glucoprivation (Song et al., 2009)
and the present results show that this effect is attenuated by propranolol pretreatment,
suggesting that β-AR-dependent lipolysis drives IWAT afferent spiking (Fig 8b, c).
IWAT afferent activation appears to be reliant on local CL-induced lipolysis, as
evidenced by increases in: 1) WAT HSL phosphorylation, 2) neurophysiological spike
activity of WAT afferents, and 3) c-Fos immunoreactivity in adipose tissue-connected
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sensory spinal neurons in the DRG. Furthermore, blocking CL-induced lipolysis with
DMP pretreatment attenuated WAT CL-induced HSL phosphorylation (Fig. 9a) and
blocked IWAT afferent activation (Fig. 8b, c). Although we did not observe increases in
WAT ATGL protein content 15 min after CL injections, pHSL was significantly higher
(Fig. 9a, b) demonstrating enhanced β3AR stimulation as a proxy for WAT lipolysis. To
further support the hypothesis that lipolysis activates WAT afferents, we then tested two
fatty acids known to be highly released during norepinephrine-induced lipid
mobilization (Raclot & Groscolas, 1993) and both EPA and AA were sufficient to drive
WAT afferent neurophysiological activity in the absence of CL. These data together
suggest that lipolysis products are sufficient to drive WAT afferent spiking, perhaps
relaying the amount and types of released lipid to the CNS.
Sensory nerves identified within adipose tissue—using immunohistochemistry
for CGRP and substance P as a afferent nerve markers—are predominantly located
around major blood vessels and less commonly innervate the parenchymal adipose
depot (De et al., 1998). This observation is further illustrated by electron micrographs of
the adipose cellular architecture (Cinti, 1999; Giordano et al., 1996). It is unlikely then
that WAT afferents activated by CL infusions circumvent adipocytes at their cellular
borders and most immediate site of efflux, but rather might serve as lipid sensors from
WAT at the entry point to the bloodstream. The possible role of WAT afferent lipid
sensors around major blood vessels may be to inform the CNS about the quantity and
types of lipid species entering circulation. Furthermore, the functional association
between WAT afferents and SNS outflow may exist to sense and potentially regulate
released lipid and/or adipokines from individual fat depots to the rest of the body.
Because of the variety of signals sensed, and potential for WAT to control SNS outflow
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to other tissues, perhaps the primary role of WAT afferents is to distinguish these WAT
depot-specific contributions to the bloodstream from lipid and adipokines accumulated
in the bloodstream from other WAT depots and elsewhere.
To help understand the physiological context of this newfound sensory signal, we
tested for the existence of a functional WAT to BAT neural link and for the first time
demonstrate acute sufficiency of the neural connectivity from WAT to BAT to drive BAT
thermogenesis (Fig. 12a-d). The general connectivity between WAT afferents and BAT is
not novel to these present experiments because others have measured diminished BAT
thermogenic capacity (Giordano et al., 1998) and atrophy of the BAT after the
destruction of afferents by sensory excitotoxic denervation (Cui & Himms-Hagen,
1992b; Cui et al., 1990). Albeit chronic and loss of function methods to test the necessity
of WAT afferents for healthy BAT function, these afferent lesion studies demonstrate
that our findings are not solitary but together reiterate the likely neural interaction from
WAT to BAT. Because surgical denervation blocked BAT temperatures in CL-infused
WAT (Fig. 12a-d), this WAT to BAT neural circuitry likely induces BAT thermogenesis
by either causing the adrenal release of norepinephrine or more likely the increase of
efferent neural activity to BAT directly (Bartness & Ryu, 2015). Despite the anatomical
pathway by which WAT CL infusion triggers BAT thermogenesis, we have measured an
acute and robust thermogenic response by BAT—in line with other evidence—as a novel
SNS output of the adipose afferent reflex (AAR) supported by others (Xiong et al., 2014).
Earlier reports by us and others (Murphy et al., 2013; Niijima, 1998) suggest
WAT afferents activated by leptin presumably relay an inventory signal to the brain but
also increase blood pressure via the AAR (Xiong et al., 2014), whereas we now provide
evidence that WAT afferents are activated by the local release of lipid and are sufficient
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to increase BAT temperature. Taken together, these reports identify heterogeneity
among WAT afferents. It is still unclear, however, whether single WAT afferent neurons
are receptive to both leptin and lipids or perhaps there are distinct neurons that sense
and generate these seemingly different reflexive outputs. Additionally, peripheral
afferent nerves also presumably release CGRP into their innervating tissue to which it is
unclear how decentralizing afferent fibers in this study have affected subsequent
afferent activity or adipose sensitivities to CL. Interestingly, CGRP injected directly into
BAT attenuates norepinephrine-induced thermogenesis and is innately released by BAT
afferent activation. This suggests that afferents possibly regulate adipose function via
negative feedback (Osaka et al., 1998). Despite these effects in BAT, we believe that our
within-animal design employed during neurophysiological recordings mitigates the
confounding effects of WAT afferent neuropeptide release in this study. Clearly, further
and more refined investigation is needed to interrogate WAT afferent functions to
potentially discover bidirectionally active labeled-lines of opposing or parallel metabolic
functions. The existence of apparently distinct AAR outputs suggests that lipolysisactivated WAT afferents also increase blood pressure and thereby facilitate newly
released lipid distribution throughout the body, to fuel BAT thermogenesis. Such a
system may allow us to better understand mechanisms of SNS dysregulation in human
obesity (i.e., wherein SNS is overactive and stimulated-lipolysis is high) (Bartness et al.,
2014a).
Altogether, these results provide evidence that WAT afferents—shown by us and
others to be involved in 1) SNS feedback regulation to multiple tissues (Niijima, 1998,
1999), 2) SNS-induced hypertension (Xiong et al., 2014), 3) neural SNS feedback loops
that are sensitive to insulin (Ding et al., 2015c), 4) regulation of fat deposition
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throughout the body (Shi & Bartness, 2005), and 5) food intake regulation (Yamada et
al., 2006)—increase their activity in response to the basic biological process of
stimulated lipolysis (i.e., simulated SNS outflow). In addition, one function of these
lipolysis-activated WAT afferents is to increase BAT temperature in an acute fashion: a
circuit which perhaps exists to correctly time the release of FFAs from WAT with the
engagement of thermogenic machinery in BAT. This novel sensory signal has
implications for many past and present studies examining the neural control of energy
balance during physiological challenges where SNS-induced lipolysis is high (e.g., food
deprivation, cold exposure, and glucoprivation) (Dunn & Adams, 2014); therefore, we
must continue to consider this synchrony of organ systems to more wholly understand
homeostatic mechanisms of survival during energy challenges.
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4.1 Introduction
WAT afferent functions have been examined by two primary approaches: 1) Loss
of function experiments using surgical denervation (which also removes efferent output
to WAT) or excitotoxic chemical denervation using high dose capsaicin (Jancso et al.,
1984) or resinerfertoxin (Acs et al., 1997) surgically injected into WAT of anesthetized
rodents. Results of these experiments establish the necessity of chronic WAT afferent
activity but the approaches employed have two shortcomings: the former completely
removes afferent but also efferent SNS projections into WAT, while the latter is afferent
specific but not complete, as it only targets capsaicin sensitive fibers and is believed to
decrease sensory innervation by only approximately 40-50%. Each type relies on a
surgical recovery period before function can be measured wherein nerve regrowth and
compensatory mechanisms that compensate for afferent nerve destruction may occur.
The second approach 2) is extracellular neurophysiological recordings in anesthetized
animals beginning with Niijima’s (1998) discovery that leptin activates WAT afferents
(Niijima, 1999) and used more recently with understanding mechanisms of the AAR
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(Shi et al., 2012; Xiong et al., 2012; Xiong et al., 2014). These methods—similar to that
described in chapters 2 and 3 above—are used to identify WAT afferent sensation.
Although valuable, this second approach cannot well characterize the role of WAT
afferents in metabolic and behavioral responses of awake behaving animals. It is clear
that a novel approach capable of testing real-time physiological consequences of WAT
afferent activity is needed, which would markedly impact the field of integrative
physiology.
In order to target WAT afferents specifically, we explored transgenic mouse
models that employ afferent nerve specific promotors. Advillin—transcribed by the
AVIL gene—is expressed only within neurons and is important for ganglionic
development; moreover, advillin expression is primarily peripheral and entirely limited
to afferent but not efferent neurons (Zurborg et al., 2011). Our collaborator (Y.B.S.,
NIH) has supplied mice (AVILcre+) wherein cre-recombinase is coexpressed with AVIL
on afferent but not efferent peripheral neurons (Fig. 13 from (Zurborg et al., 2011)).
These mice are viable and exhibit no metabolic deficits or observable phenotypic
differences compared with wild-type mice. As such, the AVILcre+ mice are ideal tools for
cre-dependent strategies of adipose afferent control.

Figure 13. AVILcre+ expression in mouse (modified from Zurborg et al.,2011).
X-gal staining in whole-mount spinal DRG from adult mice. Cre mediated recombination was detected in adult
AVILcre+. Figure from (Zurborg et al., 2011).
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This AVILcre+ combinational transgenic mouse model permits conditional genetic
modifications in adulthood for the first time. Cre-dependent adeno-associated viral
vectors (AAVs) that insert activation/inactivation receptors (e.g. Designer Receptors
Explicitly Activated by Designer Drugs [DREADDs]) can be utilized to test WAT afferent
control of energy balance and feeding behavior. Thus, we have designed a strategy to
infect WAT afferents with cre-dependent AAVs carrying DREADDs (Gq [excite WAT
afferents], or Gi [inhibit WAT afferents]) (Krashes, Shah, Koda, & Lowell, 2013), using
this AVILcre+ model for a novel, highly specific, and reversible chemogenetic control of
WAT afferents in vivo. Using this approach, we will measure behavioral and metabolic
consequences of WAT afferent activation/inhibition to test the effects of WAT afferent
activity on energy balance and feeding behavior.
4.2 Method and Results
This section is organized chronologically to best represent the logical
improvements to study design as new developments unfold during the assessment of
this unique chemogenetic approach of WAT afferent nerve control. As this work is in a
preliminary stage, the developing methodology and results in the following three
sections (i.e. Pilot, Experiment 1, Experiment 2) are outlined in general form.
4.2.1 Pilot experiment using AAV2 transduction of excitatory
DREADDs
AVILcre+ (n=2) mice and a wild type mouse were anesthetized and then surgically
injected with AAV2-hSyn-DIO-hM3D(q)-mCherry (10 x 1 µl injections totaling 2.0 x 1010
viral particles per loci) into IWAT to drive expression of excitatory (hM3D[q]) receptors
in IWAT afferent nerves. This viral construct and ones used in future experiments were
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all produced by Bryan Roth (Krashes et al., 2011) and deposited into the University of
North Carolina Viral Vector Core for commercially available distribution. This family of
viral constructs are packaged into a variety of AAV serotypes and designed for credependent translation of DREADD-mCherry fusion proteins by cells that express the
neuronal-specific synapsin promotor (hSyn). Furthermore, DREADDs-mCherry fusion
translation is cre-dependent due to the double-floxed inverted open reading frame
(DIO) flanking the target sequence. Thus, AAV2-hSyn-DIO-hM3D(q)-mCherry injected
into IWAT of AVILcre+ should cause hM3D(q)-mCherry (excitatory DREADD)
translation in cre-recombinase positive AVIL neurons (i.e. IWAT afferents). Two weeks
after AAV infection, mice were food deprived for 12 hr then WAT afferent nerves were
activated with clozapine-N-oxide (CNO, 0.5mg/kg i.p., DREADD agonist). Food
deprivation-induced food intake was measured at 1 and 2 hr after refeeding. Mice were
sacrificed by sodium pentabarbitol overdose, transcardially perfused, and DRGs (T12L3) extracted for histological verification of mCherry in Fast Blue labeled neurons.
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4.2.1.1 Pilot experiment: Results
This initial examination revealed a measurable attenuation of food deprivationinduced refeeding (Fig. 14a) as well as likely infection of adipose afferents evidenced by
mCherry visualization on Fast Blue labeled neurons from IWAT (Fig. 14b). Given these,
data, sample sizes were increased for future experiments and to more thoroughly
characterize the effects of WAT afferent nerve activity on metabolism.

0.7

IWAT afferents attenuate
FD-induced refeeding
WT + IWAT hm3D(q), ip CNO
Tg + IWAT hm3D(q), ip CNO

Food Intake (g)

0.6
0.5
0.4
0.3
0.2
0.1
0.0
1HR

2HR

Time after refeeding
Figure 14. Pilot experiment demonstrating probable DREADD control of IWAT afferents.
Food intake of AVILcre+ transgenic (Tg, n=2) and one wild type littermate. Mice were food deprived for 12 hours and
administered CNO upon refeeding. B) DRG (T13) hm3D(q)-mCherry visualization on AVILcre+ mouse injected with
AAV2/hSyn-DIO-hm3D(q)-mCherry dissolved in fast blue neurotracer (pseudocolored green). Animals were
sacrificed then perfused 3 weeks after infection into bilateral IWAT.
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4.2.2 Experiment 1: Chemogenetic control of WAT afferents 2 weeks
after AAV2 injection into IWAT.
Using a similar approach to pilot experiments with the addition of a new group of
mice injected with AAV2-hSyn-DIO-hM4D(i)-mCherry (inhibitory DREADD), we
submitted all mice (n=16) to our experimental model (Fig. 15). AVILcre+ and wild type
mice were injected with AAVs, and were then analyzed two weeks later for baseline body
mass, fat mass, and lean mass using time-domain nuclear magnetic resonance
technology (TD-NMR) by a MiniSpec machine (Bruker; Spring, TX). Mice were then
assigned to individual TSE PhenoMaster metabolic chamber cages (TSE Systems;
Chesterfield, MO) where energy expenditure, respiratory exchange ratio (RER), food
intake, and locomotor activity were measured. After 3 days of acclimation, cages were
cleaned and fresh bedding was given. All mice were given 0.5 mg/kg CNO twice daily for
the remaining 4 days in metabolic chambers. On Day 1 and Day 2 after acclimation,
mice were fed ad libitum, followed by a 24 hr food deprivation, then refed with
continuous measurements for the remaining 16 hr (Fig. 15). After 7 days, all mice were
removed from metabolic chambers, reanalyzed for their body composition, and then
returned to their home cages. One week later, all mice were euthanized for histological
verification of viral transfection.

Figure 15. Timeline for metabolic chamber experiments using AAV2 transfection of DREADDs.
Metabolic chamber characterization of ad libitum fed mice given twice daily CNO for 3 days.
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4.2.2.1 Experiment 1: Results

Figure 16. Experiment 1: Metabolic consequences of hm3d(q) activation of IWAT afferent nerves.
Food intake was significantly lower in AVILcre+ mice before and after CNO was administered. *p < .05, **p < 0.01.

Unlike the pilot data acquired at the onset of this study, we observed no or trivial
differences among treatment groups across all measures (Figs. 16, 17). In addition,
confounding food intake differences between AVILcre+ and wild type mice were present

Figure 17. Experiment 1: hm4d(i) inhibition of IWAT afferent nerves does not produce a robust
phenotype.
Energy expenditure was significantly lower in AVILcre+ mice before and after CNO was administered. *p < .05, **p <
0.01.
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during acclimation before CNO was administered (Fig. 16c). No differences in energy
expenditure were detected on days where CNO was administered. Of note, the only
difference in energy expenditure was between hm4D(i) AVILcre+ and wild type mice
during acclimation before any exposure to CNO (Fig. 17a). Postmortem assessment of
AAV2 transduction of mCherry revealed that previous pilot characterization of
endogenous mCherry (viral-mediated mCherry fluorescence) may have been nonspecific
fluorescence apparent also in wild type mice (Fig. 18, top). We were able to confirm
transduction of mCherry only after IHC in fixed DRG sections. Robust and specific
mCherry fluorescence was observed in AVILcre+ mouse neurons, suggesting that AAV2-

Figure 18. AAV2 translation of mCherry and c-Fos response to CNO.
Top) mCherry fluorescence without IHC amplification in wild type (left) and AVILcre+ mice (right). Middle) IHC
amplification of mCherry with Alexa 488 (green). Bottom) c-fos immunoreactivity 60 min after CNO 0.5mg/kg.
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hSyn-DIO viruses successfully infect and sufficiently transduce mCherry-hm3D and
mCherry-hm4D expression (Fig. 18, middle).
Due to 1) the ambiguous endogenous mCherry fluorescence in DRGs, 2)
equivalent CNO-induced c-fos between groups (Fig. 18, bottom), 3) underwhelming
phenotype from what theoretically should be a vigorous and chronic activation of IWAT
afferents, and 4) differences between the pilot data and data acquired in this
experiment, we conclude that DREADD control of these nerves was not effectively
accomplished. In Experiment 2, we define particular strategies we used to enhance the
likelihood of AAV transfection, effective measurement, and assessment of this WAT
afferent nerve chemogenetic approach.
4.2.3 Experiment 2: Chemogenetic control of WAT afferents 6 weeks
after AAV8 injection into IWAT and GWAT.
Viral trafficking efficiency of AAVs is not contiguous among the variety of
serotypes (Castle, Gershenson, Giles, Holzbaur, & Wolfe, 2014). Correspondence with L.
Vulchanova (Schuster et al., 2014; Schuster et al., 2013) and examination of the
retrograde/trafficking efficiency of various serotypes discriminates against the use of
AAV2 as a highly efficient virus for viral uptake/trafficking from neural process, but
rather suggests AAV8 and AAV9 as more robust alternatives. Commercial availability of
AAV8-hSyn-DIO-hm3/4D (UNC Vector Core; Chapel Hill, NC) allows efficient access to
a more robust transduction agent to target sensory terminals. The enhanced efficiency
of AAV8 compared with AAV2 likely will improve the efficiency of mCherry-DREADD
translation by WAT afferents and thus their activity induced by CNO (Zheng et al.,
2010). Although AAV8 is less efficient for retrograde transport than is AAV9 (Schuster
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et al., 2014), its cost and immediate availability makes it preferred over AAV2 in order to
improve endogenous mCherry expression and likely DREADD translation. Also in an
effort to improve AAV8-induced translation of mCherry and DREADDs, we increased
the duration of time after infection from two weeks to six.
Activation of adipose afferents only from IWAT may be insufficient to drive a
reproducible behavioral and/or physiological phenotype. Considering this possibility,
we also infected bilateral GWAT to control adipose afferents from four total fat pads
simultaneously. We believe that if any effect is to be achieved by adipose afferent
control, increasing the number of infected adipose afferent neurons may improve the
likelihood of producing a discernable phenotype. Because both GWAT and IWAT
afferents are leptin sensitive (Murphy et al., 2013; Shi et al., 2012), produce similar SNS
increases in anesthetized rats, and connect with similar level DRGs (T12-L3), it is likely
that that GWAT and IWAT afferent activation together produces a stronger cohesive
effect rather than two conflicting/counteracting effects.
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Figure 19. Timeline for Experiment 2a-f using AAV8 DREADD 6wks after infection.
Experiment 2a-f in chronological order. The same AVILcre+ and wild type mice were subjected to four experiments (a-d)
between 6-10 weeks after viral infection then sacrificed at the end of BAT/core temperature measurements. a) Food
deprivation-induced refeeding experiment conducted by manual food weight measurement 1, 2, 4 hr up to 6 days after
CNO+refeeding. b) Metabolic chamber characterization of ad libitum fed mice given daily CNO for 3 days. c) Blood
glucose measurements in response to CNO. d) BAT and body temperature in response to CNO of anesthetized mice. e-f)
postmortem assessment of mCherry expression and neuronal activity of dissociated cultured DRG neurons (e) and fixed
DRG histological sections (f).

CNO is used throughout the literature in the context of hm3D(q) stimulation at
doses ranging from 0.3 mg/kg (Krashes et al., 2011) to 3.0 mg/kg (Nicoleau, Nation,
Kinsman, Browning, & Stocker, 2016). The dose of 0.5 mg/kg was in the pilot study and
Experiment 1, it is unclear if this dose is sufficient to induce WAT afferent nerve control
given this unique strategy using peripheral DREADDs. Thus, we have increased the
CNO dose to 3.0 mg/kg as this has still been shown to be inert in wild type mice
metabolism and imbues greater confidence that DREADDs will be stimulated even after
low viral efficiency. Importantly, there is little evidence to suggest sensitization of
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animals to CNO based on high and/or multiple doses (Roman, Derkach, & Palmiter,
2016).
Automated metabolic chamber food intake measurements do not account for
food spillage (i.e. food removed from automated hoppers that remains in soiled bedding
and not eaten) and could explain differences in measured food intake between the pilot
and Experiment 1. Therefore, we first food deprived animals for 12 hr then manually
weighed food 1, 2, 4, 24 hr, and each day for 6 days after refeeding. This was performed
to best mimic the pilot experimental design. In addition to these measures and the use
of metabolic chambers in Experiment 1, additional experiments were added in
Experiment 2 to test the role of WAT afferent activity on blood glucose and BAT
thermogenesis (Fig. 19c-f). These experiments were added to investigate known effects
of WAT afferent activity on other systems (Ding et al., 2015b; Niijima, 1998).

Figure 20. Experiment 2a: AAV8-hm3d(q) activation of IWAT and GWAT afferent nerves does not
produce a food intake differences after food deprivation.
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4.2.3.1 Experiment 2 results
Unlike the pilot data acquired at the onset of this study, we observed no or trivial
differences among treatment groups in food deprivation-induced feeding (Figs. 19a, 20)
or food intake and energy expenditure measures within metabolic chambers (Fig. 19b,
21). This was clear in all time points measured after food deprivation-induced refeeding
(Fig. 19a, 20), but less clear in wild type and AVILcre+ mice housed in metabolic cages

Figure 21. Experiment 2b: AAV8-hm3d(q) activation of IWAT and GWAT afferent nerves does not
produce robust differences in metabolic measures.
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Figure 22. Experiment 2d: AAV8-hm3d(q) activation of IWAT and GWAT afferent nerves does not
produce a differences in BAT or body temperature.

(Fig. 21a, b). Similar to Experiment 1, AVILcre+ mice infected with AAV8-hm3D had
different baseline food intake (Fig. 16c) during metabolic chamber acclimation before
CNO was given compared with wild type mice (Fig. 21a, inset). Unlike Experiment 1,
Experiment 2b AVILcre+ ate more than wild type mice (Figs. 16a, 21a). This result could
be due to the previous exposure to CNO which was given eight days prior in Experiment
2a (see timeline Fig. 19). Accordingly, CNO could be causing delayed or chronic feeding
effects beginning with injections during Experiment 2a and continuing to affect baseline
differences in feeding during Experiment 2b (Fig. 21b) conducted on the following week.
However, the difference between AVILcre+ mice in Experiment 1 and AVILcre+ mice in
Experiment 2b is unclear, but may be driven by higher food spillage of AVILcre+ mice in
Experiment 2b (data not shown). CNO treatment increased locomotor activity (Fig. 21c)
but did not affect energy expenditure. Body composition at any time points measured
was not different between treatment groups (data not shown). Metabolic chamber data
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Figure 23. Experiment 2c: AAV8-hm3d(q) activation or AAV8-hm4d(i) inhibition of IWAT and GWAT
afferent nerves does not produce a differences in blood glucose.

for AAV8 hm4D(i) injected AVILcre+ and wild type mice were corrupted by non-stable
reference CO2 measurements and thus are inconclusive (data not shown).
Neither BAT temperature (Fig. 22) nor blood glucose (Fig. 23) was affected by
CNO injection in AVILcre+ or wild type mice. Reminiscent of baseline food intake
differences in Experiment 2b, BAT temperature was higher in AVILcre+ mice at baseline.
Much like the above possibility, this baseline difference could be due to the prior
administration of CNO from Experiments 2a-c (Fig. 19).

Figure 24. Experiment 2e: CNO applied to dissociated mCherry-positive DRG neurons from AVILcre+
mice increases intracellular calcium.
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Postmortem analysis revealed mCherry positive cultured DRG neurons from
AVILcre+ mice infected with AAV8-hm3D(q); furthermore, we identified intracellular
calcium increases after CNO bath application (Fig. 24). DRG neurons positive for
mCherry increased intracellular calcium after CNO application suggesting excitatory
DREADDs [hm3D(q)] were present and functional on WAT afferents infected with
AAV8. Similarly, CNO application modestly decreased intracellular calcium of mCherry
positive neurons with inhibitory DREADDs [hm4D(i)] (data not shown). These data
collectively indicate that DREADDs can be inserted on WAT afferents, and that
endogenous mCherry expression can be detected in dissociated DRG neurons without
the use of antibodies. This finding constitutes the largest degree of success for our
approach thus far. These positive control experiments establish that our method for
DREADD insertion is robust and infects approximately 80% of the neurons observed

Figure 25. Experiment 2e: CNO applied to dissociated mCherry-positive DRG neurons from wild type
mice injected with hm3d(q) increases intracellular calcium.
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(J.T.G., unpublished observations), a percentage of total DRG neurons homologous to
H129 transneuronal labeling efficiency of IWAT afferents (Song et al., 2009).
Unfortunately, we also have also accumulated evidence to suggest that either
because of impure AAV8s obtained commercially, and due to the large volumes of total
virus injected into each animal (~32 µl across all four WAT pads), mCherry expression
and CNO-induced calcium changes are observed in both AVILcre+ and wild type mice.
Indeed, DREADD expression using the viral construct delivered by AAV8 is nonspecific. Our negative control groups [wild type injected with AAV8-hSyn-DIOmCherry-hm3D(q)/hm4D(i)] robustly express mCherry in DRGs across all levels
extracted T12-L3 and dissociated cultured neurons. Neurons from wild type injected
with AAV8-hm3D(q) were activated by CNO application to the same magnitude and
latency of AVILcre+ neurons (Fig. 25). The exact problem that led to these results is still
under investigation but appears to be driven both by inconsistency in the viral
constructs as well as high viral injection titres/volumes used in these studies.
4.3 Discussion
The surprising findings of non-specific DREADD insertion in Experiment 2 pose
two major problems for our novel approach to control adipose afferent nerve activity. If
AAV8s are causing mCherry-hm3D(q) expression in neurons that are negative for crerecombinase then 1) WAT afferents in our wild type negative control mice were
activated to a similar degree as afferents in our AVILcre+ experimental mice, and 2) SNS
neurons in all animals injected are presumably being infected and activated as well.
These two problems limit our ability to draw conclusions from any of the experiments
using viral constructs delivered by AAV8 (i.e. Experiments 2a-f, Fig 19).
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It is possible that AAV2 infection specifically caused mCherry-DREADD
translation within cre-recombinase positive neurons, yet a reliable phenotype was not
achieved due to shortcomings discussed above from Experiment 1 to Experiment 2 (e.g.
CNO dose, number of fat depots injected, time after infection, added experiments, see
Fig. 19). Thus, methods involving AAV2-induced DREADD expression may be replicated
in the future in addition to assessing the validity of AAV9 retrograde transport (Schuster
et al., 2014). Overall, refined control experiments must be conducted before meaningful
conclusions can be reached as to the capacity of WAT afferents to affect physiology in
vivo.
4.4 Author contributions
J.T.G. designed the chemogenetic approach to WAT afferent nerve control. Transgenic
mice were supplied by Y.B.S. through collaboration with T.J.B.. J.T.G. performed the
AAV injections and subsequent characterization of the CNO-induced phenotype at all
levels. E.B. assisted with metabolic chamber assessment, M.A.T. with the blood glucose
and BAT temperature experiments, L.A. with DRG culture and calcium imaging
experiments, and V.R. with ganglia extraction. Supported by NIH R37DK035254 to
T.J.B., NIH DK105441-01 to G.J.S., and NIH R01DK035254 to B.X.
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5

CONCLUSIONS AND FUTURE DIRECTIONS

We have expanded the known sensitivities and capacities of adipose afferents by
demonstrating their 1) within-BAT neural feedback circuits, 2) sensitivities to BAT
thermogenesis, and 2) role as lipid sensors. We also have identified a functional neural
link between WAT and BAT that drives thermogenesis. The novelty represented by this
body of work lies within our particular strategy employed to test the effects of adipocytederived signals on adipose afferents rather than their sensitivity to exogenously injected
ligands [e.g. leptin (Niijima, 1998), capsaicin (Shi et al., 2012)]. In addition, our
bilateral simultaneous neurophysiological recording technique demonstrates that WAT
afferents are able to distinguish local signals from circulated factors. Together, these
data highlight an emerging role of these sensory fibers in their sensitivities and potential
to exert control of basic adipocytes functions. Future explorations of this system seek to
discover unique strategies to treat obesity by the specific neural control of WAT and
BAT functions.
Taken together, the similar potential of WAT and BAT afferents to sense SNSdirected adipose activity reveals a novel signaling mechanism of energy depletion to the
brain. Importantly, adipose afferents seem to be sensitive to many signals (e.g. leptin,
adenosine, bradykinin, lipolysis, thermogesis) but the precise segregation of these
signals has not been explored. Because of the multiunit approach to measuring adipose
sensitivities, we and others can only describe macro activation of entire peripheral
nerves that knowingly contain many individual firing units. Future explorations with
enhanced neuronal precision need to disentangle these signals to test whether these
activators increase spiking in individual parallel pathways integrated at their point of
convergence or whether all adipose afferents are each activated by these excitatory
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events and transduce the milieu of signals beginning at the tissue level. Possibly, the
adipose afferents share similar organization to vagal afferent innervation whereby
specific neurons send parallel messages (e.g. stomach stretch, nutrient intake) from the
gut to the brain for central processing (Williams et al., 2016).
Although many studies—including ours above—demonstrate adipose afferent
activators, none have described a single ligand or process capable of inhibiting this
neuronal population. Inhibitory mechanisms of this circuit are critical to elucidate
because of the seemingly feed-forward capability of this SNS-induced lipolysis sensing
circuit that promotes SNS increases (Niijima, 1999). Finding the anatomical level and
process of adipose afferent inhibition may be key to discovering how obesity—a state
where adipose afferent activators are high (e.g. leptin, lipolysis)—and hypertension (i.e.
an output of the adipose afferent reflex) are interrelated.
Our unique chemogenetic approach to control WAT afferent activity, although
largely inconclusive as to if these afferents affect in vivo metabolic processes, showed
that AAV-induced translation of functional DREADDs on WAT afferents is possible.
This positive result will guide future advancements into how we can discover the
function of these and other adipose afferents. These principles cannot only be extended
to measure functional effects of BAT afferents but also to test the necessity and
sufficiency of afferents from other organs (e.g. muscle, gut, liver). In addition, specific
control of adipose afferents could prove clinically beneficial given their dysregulation in
obesity hypertension (Xiong et al., 2012). Stepwise and progressive experiments that
test the potential capacities of WAT and BAT afferents will continue to deepen our
understanding of the complex integration of adipose tissue physiology with energy
balance.
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